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Deciphering the C-Type Lectin Receptor Signaling Pathway in Macrophages in 
Response to Candida albicans 
Publication No.__________________ 
Sara Gorjestani, M.S.  
Supervisory Professor: Xin Lin, Ph.D. 
Candida albicans causes opportunistic fungal infections in humans and is a 
significant cause of mortality and morbidity in immune-compromised individuals. Dectin-2, 
a C-type lectin receptor, is required for recognition of C. albicans by innate immune cells 
and is required for initiation of the anti-fungal immune response. We set out to identify 
components of the intracellular signaling cascade downstream of Dectin-2 activation in 
macrophages and to understand their importance in mediating the immune response to C. 
albicans in vivo. Using macrophages derived from Phospholipase-C-gamma 1 and 2 (PLCγ1 
and PLCγ2) knockout mice, we demonstrate that PLCγ2, but not PLCγ1, is required for 
activation of NF-κB and MAPK signaling pathways after C. albicans stimulation, resulting 
in impaired production of pro-inflammatory cytokines and reactive oxygen species. PLCγ2-
deficient mice are highly susceptible to infections with C. albicans, indicating the 
importance of this pathway to the anti-fungal immune response. TAK1 and TRAF6 are 
critical nodes in NF-κB and MAPK activation downstream of immune surveillance and may 
be critical to the signaling cascade initiated by C-type lectin receptors in response to C. 
albicans. Macrophages derived from both TAK1 and TRAF6-deficient mice were unable to 
activate NF-κB and MAPK and consequently failed to produce inflammatory cytokines 
characteristic of the response to C. albicans. In this work we have identified PLCγ2, TAK1 
and TRAF6 as components of a signaling cascade downstream of C. albicans recognition by 
C-type lectin receptors and as critical mediators of the anti-fungal immune response. A 
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mechanistic understanding of the host immune response to C. albicans is important for the 
development of anti-fungal therapeutics and in understanding risk-factors determining 
susceptibility to C. albicans infection. 
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Chapter 1: Introduction 
 
1.1. Opportunistic fungal pathogens 
 
Of 1415 species of known pathogenic infectious organisms for humans, 307 species are 
fungi (1). The molds, which comprise the majority of fungal species, grow as multicellular 
filaments. The evolutionary advanced forms of molds grow hyphae containing septa, which 
divide the filaments. Fungal infections in humans can cause cutaneous, subcutaneous, 
allergic and systemic diseases. Fungal infections can be divided into two types. The first 
group is virulent fungi that are pathogenic regardless of an adequate host immune system 
such as Blastomyces, Histoplasma and Paracoccidiodies. The second group constitutes low 
virulence fungi that need immunocompromised host or an altered bacterial flora to manifest 
as an infection (2). The most common opportunistic fungal infections today are the 
Aspergillus and Candida species. 
Aspergillus species causing invasive infections have an incidence of 5-24% in acute 
leukaemia and 25-40% in chronic granulomatous disease (3). Candida species are the fourth 
most common bloodstream pathogen found in hospitals (4). Candida species are found as 
colonizers of the genitourinary, gastrointestinal tracts and at lower levels it is found on the 
skin. Of Candida species, Candida albicans is responsible for approximately 95% of vaginal 
Candida infections (5). From approximately 200 species of Candida only a few species are 
known to cause infections in humans. Aside from C. albicans, C. krusei, C. glabrata, C. 
parapsilosis are known for candidiasis (6). The bacterial flora at different body sites is a 
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major determinant of Candida colonization. Although the mechanisms are not well 
understood, competition for nutrients is thought to play a pivotal role. For example 
lactobacilli residing in the vagina produce lactic acid and hydrogen peroxide, which creates 
an environment that is not ideal for Candida growth (7). Furthermore the ability of C. 
albicans to adapt to different niches in the host is important for the switch to pathogenicity. 
In different host niches the accessibility to nutrients and pH varies (8). When colonization 
by C. albicans does occur, the host niche may change by C. albicans metabolizing nutrients 
thereby changing the pH and possibly damaging the host tissues (8). 
Candidemia can be a life-threatening infection, especially in immunocompromised 
and critically ill patients (9, 10). Although C. albicans still remains the predominant strain to 
cause candidemia, in recent years there has been a progressive shift in infections caused by 
non-albicans species (11, 12). The most common non-albicans species causing candidemia 
are Candida glabrata, followed by Candida krusei and Candida tropicalis (13). Candida 
infections can affect any hospitalized patient but are more common in certain populations, 
including patients with cancer, hematological malignancy or other immunosuppression. 
Factors predisposing all intensive care unit patients to candidemia include, intravascular 
catheters, use of broad-spectrum antibiotics, diabetes, transplantation, corticosteroid therapy, 
acute renal failure, haemodialysis and pancreatitis (14). 
 
1.2 Candida dimorphism 
Candida albicans is known to be able to grow in multiple morphological forms. At 
the epithelial surfaces Candida species colonize only as yeasts. Candida yeast are ellipsoid 
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single cells which divide by budding. In order to successfully invade the host tissue Candida 
hyphal growth is necessary which has been demonstrated by Candida mutants which are 
incapable of germinating (15). Hyphal growth starts from a germ tube that extends into a 
long filament where the cells are separated by septae (16). In between the yeast and hyphal 
forms C. albicans can also grow in a variety of forms referred to as pseudohyphae in which 
the daughter cell forms a septa but remains attached to the mother cells in an elongated 
form. The switch from yeast to filamentous form can be triggered by various environmental 
conditions. Experimentally, hyphal growth can be triggered from yeast cells by adding 
serum and culturing at temperatures of 37°C. In addition, Lee’s media which is nutrient-poor 
or chemical inducers such as N-acetyl-glucosamine, together with culturing at of 37°C can 
also induce hyphal growth (17). The yeast to hyphae transition is under transcriptional 
control and genes that regulate the hyphal stage are regulated by a complex network of 
signaling pathways (18). Serum-induced filamentation is under the control of the 
transcription factor Tec1 (19). Alkali induced filamentation is controlled by the transcription 
factor Rim101 (20). In addition to these transcription factors, there are numerous other 
transcription factors that have been shown to regulate yeast to hyphal transition under 
certain growth conditions (17).  
The cyclic AMP–protein kinase A complex (PKA) pathway is a major pathway in C. 
albicans, which can induce hyphal growth. A range of environmental signals can regulate 
cAMP-PKA activation, either by direct or indirect activation of adenylyl cyclase (21). When 
C. albicans is grown at high densities, this can lead to the accumulation of the quorum 
sensing molecule farnesol, that can downregulate cAMP-PKA signaling, thereby inhibiting 
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hyphal formation. This indicates that cell density at sites of infection can also affect C. 
albicans morphogenesis (22). 
In addition to the yeast to hyphal transition, C. albicans can also switch from a white 
round yeast morphology to an elongated form termed opaque, that has an altered cell surface 
structure (23). Most C. albicans strains are MTLa/α heterozygous and can produce the a1-α 
2 repressor, which inhibits white to opaque switching by inhibiting the expression of WOR1 
gene (24). The opaque cells are thought to be the mating-competent form of C. albicans and 
strains that are homozygous at the mating type locus (MTLa/α) are able to switch from the 
white to opaque form (25). 
The white to opaque switch can contribute to better adaptation of C. albicans to the 
host niches. The switch between white and opaque forms occurs at a low frequency. This 
low frequency of switching allows a partially stable maintenance of the white and opaque 
forms and ensures that in a population some cells are preadapted to altered environments 
when encountering new host niches (26). In host niches with lower temperatures, such as the 
skin, it is thought that C. albicans switching from white to opaque may facilitate mating 
(27). White to opaque switching not only occurs spontaneously but also can be induced by 
environmental signals. Anaerobic conditions can induce white to opaque switching that is 
mediated by the transcription factor Czf1p. This anaerobically induced switching can occur 
in the mammalian gastrointestinal tract at 37° (24). The white to opaque switching can 
influence virulence as macrophages preferentially phagocytose white cells (28).  
 
 
	  	  	   	  	  	  
	   6	  
1.3 Candida cell surface 
 
Candida cell wall is the first surface of physical interaction of the fungi with its host. 
The skeletal component of the cell wall is a structure of β-glucans and chitin. Aside from the 
skeletal components the cell wall matrix is composed of glycosylated proteins, which 
represent about 40% of the dry weight of the cell wall (29). Mannoproteins, which are used 
as markers for discriminating between fungal species, are bound to the β-glucan and chitin 
layer. β-(1,2)-mannans are absent in S. cerevisiae but are present in three different types in 
different Candida species (30, 31). From the polysaccharides in the fungal cell wall β-
glucans are the most abundant. They are found as β-(1-3)- linked glucose polymers that 
contain β-(1-6)-linked side chains. In order for the chains of β-(1-3)- glucans to grow, a 
transglycolysation of glucosyl residues from the UDP-glucose to polysaccharide chains must 
occur (32). Mannans and glucans can be released by C. albicans into the surrounding 
medium such as infected patients blood and in mouse models these molecules have been 
shown to induce coronary arthirits and anaphylactic shock (Nakagawa 2003). 
The cell wall proteins present in C. albicans are two classes. The most abundant 
class, glycophosphatidylinositol (GPI)-anchored cell wall proteins (GPI-CWPs) are linked to 
β-1,6- glucans.  The second class are named Pir proteins which are directly linked to β-1,3- 
glucans (33). From (GPI)-anchored cell wall proteins, the agglutinin-like sequence (ALS) 
gene family are the best characterized. These proteins promote the adhesion of C. albicans 
to host tissues (34, 35). Immunohistochemical approches show the expression of of ALS 
proteins in C. albicans infecting mouse liver, heart, lungs and kidneys (36). Cell wall 
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proteins can also affect the pathogenicity of C. albicans. Many C. albicans mutants that lack 
cell wall proteins have reduced virulence and extracted cell wall proteins can induce arthritis 
in mice (37). 
 
1.4 Innate immunity  
 
When infections occur, the host immune system has developed specific cellular and 
molecular mechanisms to fight infections. These reactions typically are accompanied by 
signs of an inflammatory response, which include heat, swelling and pain. The host anti-
fungal immune responses range from innate immune recognition to adaptive immunity. The 
phagocytic family of innate immune cells consists of neutrophils and macrophages. Innate 
immune cells can react to pathogens immediately through responses such as phagocytosis, 
production of reative oxygen species, production of lytic enzymes and nitric oxide (38). 
Neutrophils are the most abundant leukocyte in the blood and are the very first responders to 
infections due to their ability to rapidly cross through the vessel endotheliums and 
phagocytose and kill the pathogens in the infected tissues (39). Furthermore, tissue-resident 
dendritic cells and macrophages can produce an array of cytokines and chemokines to create 
a site of local inflammation. These secreted pro-inflammatory cytokines and chemokines 
alongside antigen presentation from innate immune cells are essential for initiating an 
adaptive immune response (40). In addition these cytokines and chemokines can interact 
with endothelial cells in capillary vessels at the sites of infection to loosen endothelial cell-
cell contact and produce specific adhesion molecules. These adhesion molecules are 
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important for the recruitment of phagocytes to endothelial cells and their invasion into 
infected tissue (41, 42). 
  The innate immune cells have evolved in a manner that they only recognize 
structures that are present on pathogens therefore, eliminating the possibility of attacking the 
host mammalian cells. These structures have been named pathogen-associated molecular 
patterns (PAMPs) and their respective receptors are now known as pattern recognition 
receptors (PRRs).  Neutrophils express moderate levels of Toll-like receptors (TLR) and 
high levels of Fc gamma receptors and complement receptors. Monocytes express moderate 
levels of C-type lectin receptors but high levels of TLRs. Macrophages and dendritic cells 
express high levels of both TLRs and C-type lectin receptors (43) (Table. 1).  In the 
following sections I will focus on C-type lectin receptors and their prominent role in 
mediating fungal immunity. 
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Table 1. Recognition of Fungi by Innate Immune System. 
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1.5 C-type lectin receptors  
 
C- type lectin- like receptors are a family of proteins that have been characterized by 
containing one or more C-type lectin-like domains.  The C-type lectin receptors are pattern 
recognition receptors that recognize carbohydrate structures with their extracellular carboxy-
terminal domains (44). On the basis of their domain organization and phylogeny, C-type 
lectin receptors have been divided into 17 families (45) but members of the group II and V 
have become of particular interest for their roles in mediating fungal immunity (45). The C-
type lectin receptors that are known to recognize C. albicans are Dectin-1, Dectin-2, Mincle 
and galectin-3. 
 
Dectin-1 is a fungal recognition receptor first identified on dendritic cells that signals using 
a non-classical immunoreceptor tyrosine-based activation motif (46). Dectin-1 is primarily 
expressed in myeloid lineage cells such as dendritic cells, macrophages and neutrophils (47). 
Dectin-1 is a glycosylated type II transmembrane protein, containing a extracellular C-type 
lectin domain (CTLD), a stalk region that links the CTLD through a transmembrane region 
to an intracellular tail containing a ITAM-like motif (47). Dectin-1 couples to Syk to induce 
the classical NF-κB pathway (48). Dectin-1 can also activate the non-classical NF-κB 
pathway by activating RelB (49). Dectin-1 can recognize β-1, 3 glucans and is required for 
phagocytosis (50, 51). Upon zymosan stimulation Dectin-1 and Syk are both required for 
ROS production (52-54). The importance of Dectin-1 in mediating antifungal immunity is 
highlighted in Dectin-1-deficient mice which display high mortality rates in systemic 
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infections with C. albicans and are impaired in cytokine production compared to WT 
controls (54). In a macrophage-specific Dectin-1-deficient mouse model, Dectin-1 is 
necessary to control fungal gastrointestinal infection (55). In humans polymorphisms in the 
Dectin-1 gene, which result in an early stop codon, implicate an important role for this 
receptor in antifungal immunity in humans. Patients homozygous for this mutation are more 
susceptible to mucocutaneous candidiasis and are defective in cytokine production (56). 
This indicates that the immune mechanisms recognizing the invasive hyphal form of 
Candida are intact in these patients.  
Aside from C. albicans, Dectin-1 can recognize Aspergillus fumigatus, which is a 
frequent fungal infection in immunosuppressed individuals causing invasive pulmonary 
aspergillosis (57). The recognition of A. fumigatus was dependent on the morphology since 
germ tubes were phagocytosed and killed by ROS but conidia could only induce these 
responses upon swelling that reveals concealed β-glucans (58). Dectin-1-deficient mice 
show increased mortality rates and impaired cytokine production in vivo in response to A. 
fumigatus infection (59). 
 
Dectin-2.  The Dectin-2 receptor was first identified in a murine langerhans cell line (60).  
The Dectin-2 receptor shows specificity for mannose structures (61). This receptor primarily 
recognizes hyphal forms of fungi (62). Dectin-2 contains a short N-terminal intracellular 
domain that associates with FcγR chain through the arginine residue in its cytoplasmic 
domain to induce its signaling (63). The generation of Dectin-2 knockout mice shows that 
Dectin-2 is the receptor recognizing α-mannans found in C. albicans cell wall. Interestingly 
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Dectin-2 does not recognize β-mannan because BMDCs stimulated with cell wall mannans 
that were depleted from β-mannans could still induce similar levels of cytokines compared 
to natural Candida mannans and in both cases Dectin-2-deficient BMDCs could not produce 
cytokines (64). Furthermore, Dectin-2 is the only Syk-coupled C-type lectin receptor to be 
asscociated with helminth infections. Dectin-2 can recognize soluble components from the 
eggs of Schistosoma mansoni, thereby activating Syk and the NLRP3 inflammasome (65). 
Allergens from dust mites (Dermatophagoides farinae and Dermatophagoides 
pteronyssinus) can also be recognized by Dectin-2, triggering the production of cysteinyl 
leukotriene (66). 
 
 
Mincle The macrophage inducible C-type lectin (Mincle) is characterized as a type II 
transmembrane protein, which has been shown to recognize C. albicans. Mincle- deficient 
mice appear to be more susceptible to C. albicans in vivo (67). Similar to the Dectin-2 
receptor, Mincle signaling depends on FcγR chain for its signaling and is thought to mediate 
its signaling through the Syk-CARD9 cascade (68). Although Mincle was not found to be 
involved in phagocytosis it has been shown to localize to the phagocytic cup (67).  
 
Galectin-3 can recognize β-1,2 linked mannosides (69) and direct binding of Galactin-3 to 
C. albicans has been shown to kill C. albicans (70). Galectin-3 can synergize with the 
Dectin-1 receptor in co-immunoprecipitation experiments. In macrophages in which 
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Galectin-3 has been knocked down there is a decrease in TNF-α production in response to 
C. albicans stimulation (71, 72). 
 
Dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN) is a receptor that 
contains a non-classical ITAM that recognizes high mannose structures. In addition DC-
SIGN has been shown to induce cellular responses namely phagocytosis (73). The role of 
this receptor in immune responses to fungi has not been elucidated but it has been proposed 
to modulate TLR-mediated responses through the Raf-kinase pathway (74). 
 
1.6. NF-κB activation 
 
 
The Nuclear Factor kappa B (NF-κB) is one of the most extensively studied 
inducible transcription factors. NF-κB was first described by Sen and Baltimore who 
identified it in B cells as a transcription factor that binds to the promoter of the kappa light 
chain of immunoglobulins (75). The NF-κB transcription factors consist of RelA, Rel B, c-
Rel, NF-κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100). These 
transcription factors play a crucial role in regulating the innate and adaptive immune system 
by controlling various processes that range from regulating the immune response to various 
stimuli to development of lymphocytes (76). The immune system responds to pathogens by 
activating the NF-κB pathway, which regulates the transcription of inflammatory genes. 
            The NF-κB signaling pathway is classified into two major pathways: the classical 
and non-classical NF-κB signaling pathways. The classical NF-κB pathway signaling 
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pathway is composed of p50: RelA and p50: c-Rel hetermodimers. These transcription 
factors translocate to the nucleus through the activation of the trimeric IκB kinase (IKK) 
complex, which consists of the catalytic subunits IKKα and IKKβ and the regulatory 
subunit IKKγ. The IKK complex becomes activated by the phosphorylation of the IKKα and 
IKKβ subunits (77) and the K63-linked ubiquitination of IKKγ (78-80). The mechanistic 
detail of how the IKK complex is activated differs between one receptor to another (81). In 
non-stimulated cells inhibitors of NF-κB, named IκB proteins retain NF-κB dimers in the 
cytoplasm. When receptors are engaged the IKK complex becomes activated and 
phosphorylates IκBα on Ser36 and Ser32. Phosphorylated IκBα then becomes ubiquitinated 
by the E3 ligase β-TrCP, leading to its subsequent K48-linked ubiquitination and 
degradation enabling the nuclear translocation of NF-κB (82, 83).  
                  The non-classical NF-κB pathways is activated by the TNF receptor superfamily 
members such as lymphotoxin β or CD40 causing the activation of NF-κB-inducing kinase 
(NIK) which in turn activates the IKKα subunits leading to the phosphorylation of p100. 
p100 can then be processed into p52 leading to the translocation of the p52/RelB dimer into 
the nucleus (84). The nuclear translocation of NF-κB enables this transcription factor to 
cooperate with other transcription factors, leading to the transcriptional induction of various 
genes, including growth factors, proinflammatory genes and anti-apoptotic proteins. The 
extracellular signaling that induces NF-κB is primarily received through transmembrane 
receptors of the TNF receptor superfamily such as Tumor Necrosis Factor alpha (TNFα), G-
protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), T cell and B cell 
antigen receptors (TCR, BCR) and Toll-like receptors (TLRs).  
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                 Although there has been a great deal of progress in understanding NF-κB 
signaling, the mechanistic details of how different receptors can activate the IKK complex 
still remains to be fully elucidated. Scaffold proteins have been shown to play receptor and 
tissue-specific roles in mediating NF-κB signaling (85, 86). A family of Caspase recruitment 
domain (CARD)-containing scaffold proteins which have been termed CARD-and 
membrane –associated guanylate kinase –like domain-containing proteins (CARMA), have 
been shown to regulate the IKK complex (87, 88). The CARMA family consists of five 
members that exhibit specific patterns in tissue distribution. CARMA1 is primarily 
expressed in hematopoietic tissues; CARD9 is expressed in the myeloid lineage of 
hematopoietic cells; CARMA3 is not expressed in hematopoietic cells but has a broad range 
of expression in other tissues; and CARMA2 is expressed in placenta (89, 90). These 
proteins have a similar structure in that they all contain a N-terminal CARD domain 
followed by a coiled-coil domain. CARMA1, CARMA2 and CARMA3 contain an 
associated guanuylate kinase –like domain (MAGUK) domain, which is thought to be 
important for plasma membrane localization. However, the CARD9 family member lacks 
the MAGUK domain (88). The CARMA family members can form a complex with BCL10 
and MALT, which is referred to as the CBM complex, leading to NF-κB activation (91, 92). 
In our studies we have focused on understanding how the NF-κB signaling pathway is 
activated downstream of C-type lectin receptors (CLRs). 
 
1.7 NF-κB activation by antigen receptor signaling 
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                 In the antigen receptor signaling pathway activation of the T cell receptor and B 
cell receptors lead to NF-κB activation. Upon receptor activation the tyrosines on the 
immunoreceptor tyrosine-based activation motifs (ITAMs) become phosphorylated by Src 
family kinases, Lck and Fyn. Syk tyrosine kinases Zap70 and Syk then get recruited and 
phosphorylate SLP-76 and LAT. Phosphorylation of SLP-76 in TCR signaling induces its 
binding to Vav1. The Vav1-SLP76-Tec family tyrosine kinase Itk complex activates PLCγ1, 
which can lead to the release of diacylglycerol (DAG), thus stimulating PKCs (93, 94). It is 
proposed that PKCθ can phosphorylate CARMA1, facilitating its associating with BCL10 
(93). The activated CARMA1-BCL10-MALT1 complex leads to IKK activation. Recently 
some components that were thought to be primarily involved in TLR/IL-1 receptor mediated 
NF-κB activation such as TAK1 and TRAF6 have been shown to be involved in TCR- 
mediated IKK activation. The TRAF6-MALT1 interaction can lead to the K63-linked 
polyubiquitination of IKKγ and IKK complex activation (95). 
 
1.8 Dectin-1 and Dectin-2 signaling  
 
              Dectin-1 and Dectin-2 are characterized as type II glycosylated transmembrane 
proteins containing single CRDs that are highly conserved in humans and mice. Dectin-1 
receptor contains a tyrosine-based activation motif (ITAM)-like motif or hemITAM in the 
intracellular region of this receptor whereas Dectin-2 does not have any known signaling 
motif in its cytoplasmic regions (96). Although ITAM associated receptor signaling has been 
well defined in T cells and B cells, in myeloid cells the components for this type of receptor 
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signaling was not known until recently. Studies by Rogers and colleagues (48) showed that 
Syk is the kinase in myeloid cells that is recruited to the ITAM in the intracellular region of 
Dectin-1, where it is phosphorylated and accumulates at the phogocytosis cup.   
           The Dectin-2 receptor utilizes Syk for its signal transduction. BMDCs stimulated 
with α-mannan or Dectin-2 monoclonal antibodies induced the production of TNF, IL-10 
and IL-2 cytokines that were decreased in Syk-deficient BMDCs compared to WT (64, 97). 
Downstream of Syk the adaptor protein CARD9 can form a complex with BCL10 and 
MALT1 (98). The adaptor protein CARD9 is critical for cytokine production downstream of 
Dectin-1 and Dectin-2. Furthermore the role of CARD9 in mediating anti-fungal immunity 
is shown in vivo with CARD9-deficient mice exhibiting higher susceptibility to C. albicans 
compared to WT mice (99, 100). 
           In humans, the role of CARD9 in immune protection against Candida infection is 
demonstrated in patients harboring mutations in CARD9 by increased susceptibility to 
infections with C. albicans (101). In our recent study we found that CARD9 is required for 
Dectin-2 but not Dectin-1 mediated NF-κB activation. In addition CARD9 is regulating the 
IKK complex by the polyubiqutination of IKKγ and does not affect IKKα/β phosphorylation 
status (62) (Figure 1). In addition to the Syk-dependent classical NF-κB pathway the non-
canonical NF-κB subunit RelB can be activated downstream of Dectin-1 but in a Syk- 
independent manner (49). Ligation of Dectin-1 activates Raf-1, promoting p65 activation 
and repressing RelB activation. 
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Figure 1. C-type lectin induced NF-κB activation in myeloid cells. The C-type lectin 
receptors Dectin-1, Dectin-2 and Mincle utilize ITAMs either directly or indirectly to recruit 
Syk, leading to the activation of the CARD9-BCL10-MALT1 complex and the subsequent 
activation of the IKK complex. 
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1.9 Adaptive anti-fungal immune response 
 
            The C-type lectin receptors Dectin-1 and Dectin-2 trigger innate immune responses, 
leading to adaptive immune responses, which include Th17, Th1 and cytotoxic T-cells. The 
differentiation of Th17 cells is induced by cytokines such as IL-1β, IL-6, TGF-β, IL-23 and 
IL-21 in addition to transcription factors such as γt and retinoic acid receptor-related orphan 
nuclear receptors (102). Stimulation of Dectin-1 by purified β-glucans on antigen presenting 
cells was shown to be able to induce the differentiation of Th1 and Th17 CD4+ T-cells in 
addition to CD8+ cytotoxic T cell responses (49, 103, 104). The signaling components in 
innate immune cells that are a driving force for Th17 development are not fully 
characterized but the Syk-CARD9 and the Raf-1 signaling pathways are shown to regulate 
Th17 inducing cytokine production such as IL-23 IL-1β, IL-6 and dampen the production of 
Th-2 cytokines such as IL-12 (49, 105).  
            There is emerging evidence for the role of Dectin-1 in regulating IL-17 production in 
humans during fungal infections. The identification of a polymorphism in the Dectin-1 
receptor in humans, which prevents the expression of Dectin-1 on the cell surface, showed 
that these individuals are defective in the production of cytokines such as IL-17 and are 
susceptible to mucocutaneous fungal infections (56). In a separate study Dectin-1 
polymorphism is linked to an increase in the incidence of graft-versus-host disease 
associated with increased Candida colonization (106). Recent studies demonstrate that the 
Dectin-2 receptor plays a prominent role in inducing Th17 and Th1 responses. Upon C. 
albicans infection, Dectin-2 by signaling through the Syk-CARD9 cascade, induces Th-1 
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and Th17 T helper cell differentiation (64, 97). In these studies, stimulation of dendritic cells 
with fungal particles leads to the induction of cytokines, which include IL-6, TNF, IL-1β 
and IL-23. 
 
1.10 Tissue invasion and mucosal colonization 
 
             C. albicans hyphae predominates at the primary site of infiltration into epithelial 
cells layers, whereas yeast cells are found either on the epithelial cell surface or emerge 
from penetrating hyphae that are infiltrating tissues (107). Aside from phagocytic cells, C. 
albicans interacts with mucosal epithelial cells. Mucosal epithelial cells can recognize fungi 
and respond by producing cytokines (108, 109). In healthy individuals where small yeast 
numbers are present, epithelial cells are not damaged to trigger the production of cytokines. 
Upon crossing tissue surfaces, C. albicans can cause invasive infections. Hyphae can cause 
more epithelial damage than yeast through the production of lytic enzymes such as secreted 
asparyl proteinases (SAPs) (110, 111). Both yeast and hyphae can induce endocytosis by 
epithelial cells (112, 113), although hyphae are thought to be more efficient in stimulating 
this process (113). Epithelial cells discriminate between yeast cells and invasive hyphae by a 
two-phase MAPK pathway activation process (114). Epithelial cells in the first phase of 
MAPK activation activate the transcription factors FOS and JUN through p38 MAPKs. This 
initial MAPK activation is independent of the morphological status of C. albicans. The 
second phase of MAPK activation can only be induced by hyphae and not by the yeast form. 
In the second phase the transcription factor MAPK phosphatase 1 is activated by ERK1/2 
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and p38 MAPKs. In addition to epithelial cells, DCs and tissue resident macrophages 
constantly sample the contents of mucosal flora. However, the mechanisms that allow these 
cells to discriminate between yeast and hyphal forms need further investigation. One 
proposed model for the discrimination between the yeast and hyphal forms of C. albicans by 
mucosal immune cells is the ability to activate the NLRP3 inflammasome in these cells. In 
macrophages only hyphae can induce the activation of the NLRP3 inflammasome to induce 
IL-1β secretion (114). Under normal conditions of C. albicans colonization, no substantial 
activation of the NLRP3 inflammasome occurs and therefore low levels of pro-IL-1β is 
processed by DCs only. However, the germination of yeast cells into hyphae triggers 
NLRP3 inflammasome activation in macrophages and DCs, leading to high levels of IL-1β 
processing (115). Secretion of IL-1β by mucosal immune cells leads to the induction of 
Th17 cells, which produce IL-17 and IL-22 cytokines. IL-22 can induce the production of 
defensins by epithelial cells (116) and IL-17 recruits neutrophils to phagocytose and kill 
hyphae (117) . Furthermore damaged epithelial cells can release ATP which also in a known 
activator of NLRP3 inflammasome (118). 
 
1.11 Evasion of Candida from the host defense 
 
             One mechanism, which Candida uses to escape phagocytosis, is the shielding of 
important PAMPs from being recognized by pattern recognition receptors. β-glucan is 
shielded by the outer cell wall components, which prevents its recognition by Dectin-1 (53). 
In heat-killed C. albicans, which the architecture of the cell wall is disrupted, significant 
	  	  	   	  	  	  
	   22	  
amounts of cytokines are induced compared to live C. albicans, due to the exposure of β-
glucans (119). An important process for killing of C. albicans is the fusion of the 
phagosome with the lysosomes. Candida can inhibit the formation of phagolysosomes and 
wild-type C. albicans compared to nonfilamentous mutants has a higher capacity to control 
phagosomal composition (120). The production of ROS is an important antifungal 
mechanism is phagocytes. Candida species have evolved several defense strategies to 
counteract ROS. For example C. albicans strains that are defective in catalase production are 
less virulent and are cleared faster compared to WT strains in an experimental model (121). 
Although the recognition of fungal cell wall components are necessary for ROS production, 
Candida viability is necessary for the suppression effect (122). The quorum-sensing 
molecule farnesol is shown to decrease macrophage viability by inducing ROS (123). 
Furthermore, farnesol can protect C. albicans from oxidative stress by upregulating SOD2, 
SOD4 and CAT1 (124). It also has been demonstrated that macrophages produce higher 
levels of IL-6 when stimulated with WT C. albicans compared to farnesol-deficient strain 
(125). Although the majority of studies have focused on the mechanisms which Candida 
induces cytokine production in the host, little is known about how C. albicans exploits host 
cytokine production. Recently, it was shown that C. albicans could actively inhibit the 
host’s IL-17 production by altering host tryptophan metabolism. In this study C. albicans 
could shift tryptophan metabolism by inhibiting indoleamine 2,3-dioxygenase (IDO) 
expression, leading to more 5-hydroxytryptophan metabolites, subsequently inhibiting host 
IL-17 production (126).  
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1.12 Phospholipase gamma family 
 
In response to stimuli, activated cells amplify incoming signals by producing second 
messengers that link receptors to intracellular pathways. Inositol-1,4,5-trisphosphate 
(Ins (1,4,5)P3) and diacylglycerol (DAG) are essential second messengers that are produced 
by phospholipase C (PLC). The PLC enzymes contain a N-terminal PH domain, a catalytic 
triose phosphate isomerase (TIM) barrel, four EF-hands, and a C2 domain (127). 
In mammals there are two PLC-γ isoenzymes (PLCγ1 and 2). PLC-γ1 is expressed 
ubiquitously whereas PLC-γ2 is primarily expressed in hematopoietic cells (128) . The PLC-
γ isoforms are structurally different from other PLC enzymes due to a unique split PH 
domain, a SH3 domain and two SH2 domains. Most growth factor receptors that contain 
tyrosine kinase activity (RTKs) use PLC-γ isozymes, which cause dimerization and 
autophosphorylation of RTKs, creating docking sites for the SH2 motifs of PLC-γ isozymes 
(129, 130). In addition, PLC-γ members can be activated downstream of receptors lacking 
intrinsic tyrosine kinase activity such as B-cell and T cell immunoreceptors (131, 132). In 
these cells PLC-γ gets activated by immunoreceptor tyrosine-based activation motifs 
(ITAMs), which are coupled to the receptors. In T cells upon activation of the T cell 
receptor, Zap70 is recruited into the signaling complex by its SH2 domains (133). Zap70 
then tyrosine phosphorylates LAT and SLP-76, which are adaptor proteins (134). PLC-γ1 is 
then able to bind to SLP-76 and LAT by its N-terminal SH2 and SH3 domains respectively. 
In hematopoietic cells, PLC-γ signaling has been studied in the B-cell antigen receptor 
(BCR) pathway. In B cells upon phosphorylation of ITAMs, the spleen tyrosine kinase (Syk) 
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is recruited to the complex where it phosphorylates SLP-65 (135). SLP65 can interact with 
PLC-γ2 and Burton tyrosine kinase. Thus, the kinases Syk and Btk are thought to be 
responsible for the phosphorylation of PLC-γ2 (136).  
The goal of our study was to identify components of the intracellular signaling 
cascade downstream of C-type lectin receptor activation in macrophages and to understand 
their importance in mediating the immune response to C. albicans in vivo. A mechanistic 
understanding of the host immune response to C. albicans is important for the development 
of anti-fungal therapeutics and in understanding risk-factors determining susceptibility to C. 
albicans infection. 
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Chapter 2: Methods and Materials 
 
2.1 Generation of Bone Marrow Derived Macrophages (BMDM) 
 
Primary cultures of bone marrow-derived macrophages (BMDMs) were prepared as 
previously described (100, 137, 138). Briefly, bone marrow cells were harvested from the 
femurs and tibias of mice. Erythrocytes were removed from cells samples by subjecting the 
samples to ACK buffer, which is a hypotonic solution. Cells were cultured for 7 days in 
DMEM containing 20% FBS, 55 µM β-mercaptoethanol, streptomycin (100 µg/ml), 
penicillin (100 U/ml), and 30% conditioned media from L929 cells overexpressing 
macrophage colony-stimulating factor (M-CSF) and plated on 150 cm petri dishes. Non-
adherent cells were removed and after 7 days of differentiation the cultures were confluent 
and the cells were used for experiments. . Flow cytometry analysis indicated that the 
harvested cell population contained 86–95% CD11b+ F4/80+cells as assessed. 
 
2.2  Lentivirus-encoded shRNA knockdown of Dectin-2 in BMDMs 
 
The lentiviral vectors for Dectin-2 were purchased from Sigma. Lentiviral particles for 
infection were prepared by transfection of 293T cells (62). Mouse bone marrow cells were 
infected with virus on days 1 and 3 by spinoculation followed by incubating the cells for 4 
hours with the prepared lentivirus and selected with 2 µg/ml puromycin on day 5 of culture. 
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2.3 C. albicans preparation 
 
Candida albicans (strain SC5314) (139) was kindly provided by Dr. Michael C. Lorenz 
(Department of Microbiology and Molecular Genetics, University of Texas Medical School 
at Houston). A single colony of C. albicans was grown overnight at 30°C in yeast peptone 
dextrose media. The cells were washed three times with PBS and	  then	  used	  as live yeast. 
For hyphae, the washed yeast cells were re-suspended in DMEM with 10% FCS and grown 
at 37°C for 3 hours, and	  washed	  in	  PBS. The hyphae were then used for live stimulations. 
For heat-killed yeast the cells were incubated at 65°C for one hour. 
 
2.4 In vivo C. albicans infection 
 
For in vivo C. albicans infection, male mice aged at 8-14 weeks were injected with 2 x 105 
or 1x106 live C. albicans in 0.3 ml of PBS (pH 7.4). The mice infected were monitored daily 
to determine survival curves. Candidal burden was determined by killing the mice 42 hours 
after infection and harvesting and homogenizing their kidneys, lungs, livers, and spleens. 
Fungal colony formation units were quantified by plating serial dilutions of the 
homogenized organs on yeast extract peptone dextrose (YPD) agar. For histological 
analysis, the tissue sections were cut and stained for glycogen using Periodic Acid-Schiff or 
hematoxylin and eosin. 	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2.5 Reactive oxygen species (ROS) production assay 
 
For ROS production evaluation, 1x105 BMDMs were washed with Hank’s balanced salt 
solution without phenol red. Then 100 µL Hank’s balanced-salt solution containing 100 µM 
luminol and 5 units of horseradish peroxidase (Sigma) were added to the cells and the cells 
were incubated for 10 minutes at 37°C, The cells were then stimulated with either hyphae 
(multiplicity of infection [MOI]=2) or phorbol myristate acetate (PMA). ROS production 
was measured every 3 minutes using a luminometer. 
 
2.6  Electrophoretic Mobility Shift Assay (EMSA) 
 
BMDMs (7x106) were lysed in 250 µL of lysis buffer containing 10 mM KCl, 10 mM 
HEPES, 0.1 mM EDTA, 0.4% Nonidet P-40, 0.5 mM PMSF, 1 mM dithiothreitol and 1% 
protease inhibitor cocktail followed by a minute centrifugation at 13000 RPM at 4°C. The 
supernatant were removed and the nuclear pellet was washed once with lysis buffer. Nuclear 
extraction (30 µL) buffer containing 0.4 M NaCl, 20 mM HEPES, 1 mM EDTA and 0.5 mM 
PMSF, 1% protease inhibitor and 1 mM dithiothreitol was added to the nuclear pellet and 
the pellet was vortexed for 30 minutes at 4°C.  The nuclear proteins were collected by 
centrifugation at 13000 RPM for 10 minutes at 4°C and protein concentration was assessed 
by Bio-Rad protein assay (Bio-Rad).  Nuclear extracts (5 µg) were incubated with 32 P-
labeled NF-κB or Oct-1 probe (Promega) for 15 minutes at 25°C.  The mixtures were then 
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run on a 6% polyacrylamide gel for 85 minutes at 220 volts at room temperature. The gels 
were dried for 1 hour at 85°C on a vacuum gel dryer and exposed to X-ray fim. 
 
2.7 Cytokine production 
 
The amount of secreted TNF-α, IL-2, IL-6, IL-10, IL-12p40 and IL-1β in the culture 
supernatants was measured using ELISA according to the manufacturers recommendation 
(eBioscience, San Diego, USA). In order to increase sensitivity the supernatants were 
incubated on the ELISA plates coated with the primary antibody overnight at 4°C. 
 
2.8 Western blot analysis and immunoprecipitation 
 
To prepare proteins lysates for western blot analysis cells were lysed in 150 or 250 mM 
NaCl lysis buffer containing 50 mM HEPES, 1 mM EDTA, 1% Nonidet P-40, 1 mM 
Na3VO4, 1 mM NaF, 1 mM PMSF, 1 mM dithiothreitol and protease inhibitor cocktail 
(Roche Diagnostics, Mannheim, Germany) for 20 minutes at 4°C on a rocker. The lysates 
were centrifuged for 15 minutes at 13000 RPM at 4°C. The supernatants were collected and 
denatured with 4X SDS loading dye (20% β-mercaptoehanol, 240 mM Tris-Cl pH 6.8, 8% 
SDS, 0.2% bromophenol blue, 40% glycerol).  In experiments where immunoprecipitation 
was performed cell lysates that were prepared as described above were added to either 
protein A, G, FLAG or HA conjugated sepharose beads (Roche) that had been washed with 
lysis buffer and incubated with antibody for 10 minutes on ice in the cases were protein A or 
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G sepahrose beads were used. The samples were rotated at 4°C for 4-16 hours. The beads 
were then washed 4 times with lysis buffer. In experiments where elution of the target 
protein from FLAG-conjugated sepharose beads was needed the beads were incubated with 
elution buffer (50 mMTris-HCl, pH 7.5, 150 mM NaCl, 0.5 % NP40) and 0.5 mg/ml of 
FLAG peptide for 30 minutes then pelleted and fresh elution buffer containing FLAG 
peptide was added. This step was repeated 4 times. After immuoprecipitation and the 
washing steps, equal amount of 4X SDS loading dye was added to the beads to elute the 
target immunoprecipitated protein. Samples were then subjected to electrophoresis. The 
SDS-PAGE gels were either stained directly using sypro ruby or silver staining methods or 
they were transferred to a nitrocellulose membrane for at least 1 hour at 90 volts. 
Membranes were blocked with TBST containing 5% milk or BSA for 30 minutes.  Primary 
antibodies were diluted in TBST containing 1% BSA overnight or for one hour. Secondary 
antibodies were diluted in TBST containing 5% milk or BSA for 1 hour. The membranes 
were washed 3 times for 15 minutes each and were incubated with ECL substrate and 
exposed to the autoradiography film. 
 
2.9 Mass spectrometry 
 
Sypro ruby stained gels were visualized on a transilluminator by UV fluorescence. Gradient 
precast gels were purchased from BioRad and bands were excised from the gel using an 
ethanol rinsed scalpel. To reduce keratin contamination all procedures were performed by 
regularly changing gloves. The acrylamide gel slices were sent to the proteomics and mass 
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spectrometry facility according to the facility procedures. In gels stained by silver staining 
all procedures were done according to the manufactures protocols (Invitrogen). 
 
2.10 Calcium phosphate transfection 
 
HEK 293T cells were plated at 4.5 x104 /cm2 in DMEM containing 10% FBS and 1% 
penicillin/ streptomycin overnight. DNA (5 µg) was the maximum amount used per 106 cells 
which was mixed with 2x HBSS (280 mM NaCl, 10 mM KCl, Na2HPO4 ,12 mM Dextrose, 
59 mM HEPES), then slowly mixed with 2 M CaCL2 . After 30 minutes of incubation at 
room temperature, the mixture was gently added to the cells. 
 
2.11 Cell culture and transfection  
 
Raw264.7 cells were cultures in RPMI containing 10% FBS and 1% penicillin/ 
streptomycin. Raw264.7 was stably infected with retrovirus. Cells were rested for three days 
followed by puromycin (2 µg/ml) drug selection. 
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Chapter 3 
Phospholipase C γ2 is a critical component of the Dectin-2 signaling pathway and 
mediates innate antifungal immune responses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  	   	  	  	  
	   33	  
Chapter 3: Phospholipase Cγ2 is a critical component of the Dectin-2 signaling 
pathway and mediates innate antifungal immune responses. 
 
3. 1. Background 
 
In humans with immunocompromised immune systems the dimorphic fungus C. 
albicans causes a range of infection manifestations, from superficial and mucosal to lethal 
bloodstream infections. The innate immune cells such as neutrophils and macrophages play 
an essential role in antifungal host defense (43). The C-type lectin receptors Dectin-1 and 
Dectin-2 are important pattern recognition receptors for recognizing C. albicans cell wall 
components and initiating an immune response. β-glucan carbohydrate structures are 
recognized by Dectin-1 receptor (53, 140). These β-glucan structures are buried by 
mannoproteins in the yeast form of C. albicans but they can be exposed when the yeast 
transforms into the hyphal form (141) thereby providing an opportunity for the Dectin-1 
receptor to interact with β-glucan to induce cytokine production. The Dectin-2 receptor 
recognizes the mannan coat in the cell wall of C. albicans hyphae (63, 64). Although the 
signaling pathway components utilized by Dectin-1 and Dectin-2 are not fully characterized, 
Syk is the major kinase in this pathway leading to multiple signaling cascades (48, 97, 142-
144).  Syk is not only important in C-type lectin receptor signaling pathways but also in B 
cell receptor signaling. In B cell receptor signaling, PLCγ2 plays an essential role to mediate 
downstream receptor signaling. PLCγ can hydrolyze phosphatidylinositol 4,5-bisphosphate 
to diacylglycerol and inositol 1,4,5-triphosphate (145). In the cells of the hematopoietic 
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system, both isoforms of PLCγ, PLCγ1 and PLCγ2 are expressed. Studies performed in 
dendritic cells show that in response to β-glucan found in zymosan and curdlan preparations 
both isoforms of PLCγ can be activated through the Dectin-1 receptor (146, 147).  In our 
studies, we demonstrate that macrophages specifically utilize PLCγ2 but not PLCγ1 
downstream of the Dectin-2 receptor in response to C. albicans infection. Using mouse 
models deficient in PLCγ1or PLCγ2, we demonstrate the key role of the PLCγ2 isoform in 
mounting an immune response by the production of essential cytokines and the generation of 
reactive oxygen species, which are essential to host defense to C. albicans.  
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3.2. Results 
 
3.2.1 Hyphae stimulation leads to PLCγ2 phosphorylation through the Dectin-2 
receptor 
A previous study in bone marrow derived dendritic cells showed that in response to 
zymosan, which is a fungal cell wall extract derived from Saccharomyces cerevisiae both 
PLCγ1 and PLCγ2 are phosphorylated. To determine whether C. albicans can activate 
PLCγ2 in macrophages, we examined PLCγ2 phosphorylation in BMDMs after infecting 
them with C. albicans hyphae. Stimulation of BMDMs with C. albicans led to an inducible 
phosphorylation of PLCγ2 (Figure 3.2.1 A). This result indicated that PLCγ2 becomes 
activated in response to C. albicans infection.  Since both C-type lectin receptors Dectin-1 
and Dectin-2 are involved in antifungal innate immune responses, we evaluated whether 
PLCγ2 activation in response to hyphae is induced through these receptors. We utilized 
BMDMs from Dectin-1 knockout mice or BMDMs, which were previously treated with 
shRNA to Dectin-2 during their differentiation process. Consistent with previous findings 
from our lab which showed that hyphae-induced signal transduction primarily was initiated 
through the Dectin-2 receptor and not Dectin-1; we observed that PLCγ2 phosphorylation 
was dependent on Dectin-2 but not Dectin-1 (Figure 3.2.1 B and Figure 3.2.2). These results 
indicate that PLCγ2 is an important component of the Dectin-2 signaling pathway in innate 
immune cells. 
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Figure 3.2.1. Dectin-2 is required for C. albicans-induced PLC γ2activation. A, wild-
type macrophages were stimulated with C. albicans hyphae (MOI: 1) and the 
phosphorylation of PLCγ2 was examined by Western blotting. B, BMDMs were infected 
with lentivirus encoding Dectin-2 shRNA or GFP shRNA, then selected with puromycin, 
and stimulated on day 9 with C. albicans hyphae (MOI: 1) at different times. Cell lysates 
were subjected to Western blotting analysis using indicated antibodies. 
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Figure 3.2.2. Hyphae induced phosphorylation of PLCγ2 is not mediated through 
Dectin-1. WT and Dectin-1-/- BMDMs were stimulated with C. albicans hyphae (MOI: 1) or 
LPS (100 ng/ml) for the indicated times. Cell lysates were subjected to Western blotting 
analysis using the indicated antibodies. 
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3.2.2 PLCγ2 is required for C. albicans infection-induced NF-κB activation  
 
We next sought to identify the PLCγ2-dependent signaling pathways in macrophages 
and determine whether these signaling pathways are redundant in response to yeast and 
hyphal forms of C. albicans. Both the hyphal and yeast forms of C. albicans activate the 
transcription factor NF-κB. We stimulated PLCγ2-deficient BMDMs with the yeast and 
hyphal form of C. albicans and evaluated the DNA-binding activity of NF-κB transcription 
factor. We found that in response to both yeast and hyphal forms of C. albicans  (Figure 
3.2.3 A and B) PLCγ2-deficient macrophages were defective in NF-κB activity compared to 
WT macrophages. The dectin-1 receptor has been shown to cooperate with TLR2 to induce 
cytokine production in response to fungal infections (52, 148). Therefore, we examined the 
role of MyD88 in regulating NF-κB activation in response to hyphal and yeast forms of C. 
albicans. In contrast to PLCγ2 -deficiency, loss of MyD88 did not affect NF-κB activation 
(Figure 3.2.3 B and D). 
Considering that in the BCR signaling pathway both Syk and PLCγ2 are critical 
components for transducing signals, we investigated whether other components of BCR 
signaling, which mediate PLCγ2 activation, are required for fungal-induced NF-κB 
activation. Burtons tyrosine kinase (BTK) is known to be essential to activate PLCγ2 in the 
BCR signaling pathway (149), we evaluated the role of BTK in fungal-mediated NF-κB 
activation. We used the BTK inhibitor LFM-A13 to pretreat macrophages before 
challenging with C. albicans hyphae. We found that the BTK inhibitor did not affect PLCγ2 
phosphorylation and NF-κB activation in response to C. albicans hyphae (Figure 3.3.4).  
	  	  	   	  	  	  
	   39	  
This finding indicates that although PLCγ2 is both used in BCR signaling and innate fungal 
recognition, these signaling pathways are not redundant. The IKK complex is regulated by 
two signaling events. The ubiquitination of Nemo is regulated by the CBM complex (62, 
150) whereas the phosphorylation of IKKα/β is mediated through an independent signal. 
The adaptor protein CARD9 regulates Nemo ubiquitination, whereas Syk mediates IKKα/β 
phosphorylation. We next examined how PLCγ2 regulates the IKK complex.  We found that 
unlike CARD9-deficient macrophages, PLCγ2-deficient macrophages were defective in the 
phosphorylation of IKKα/β upon stimulation with hyphae (Figure 3.2.5). 
The adaptor protein CARD9 forms a complex with BCL10 to mediated downstream 
signaling events. We investigated the effect of PLCγ2 on the association of CARD9 with 
BCL10, by immunoprecipitating endogenous CARD9 from WT and PLCγ2-deficient 
macrophages that were stimulated with hyphae. Interestingly we did not observe any 
difference in CARD9-BCL10 association between WT and PLCγ2-deficient macrophages 
(Figure 3.2.6). These results suggest that PLCγ2 functions as a critical enzyme downstream 
of Syk and can regulate the IKK complex independent of CARD9. 
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Figure 3.2.3.  NF-κB activation induced by C. albicans hyphae and yeast is PLCγ2-
dependent. A and B, WT and PLCγ2-deficient BMDMs were either untreated or treated 
with C. albicans hyphae (MOI: 1) (A) or heat-inactivated yeast (MOI: 5) (B) for 90 min. The 
nuclear extracts were prepared from these cells and then subjected to the electrophoretic 
mobility shift assay using 32P-labeled NF-κB or OCT-1 probe. C and D, WT and Myd88-/- 
BMDMs were stimulated with C. albicans hyphae (MOI: 1) (C) or heat-inactivated yeast 
(MOI: 5) (D) for 90 min. The nuclear extracts were subjected to EMSA using 32P-labeled 
Oct-1 or NF-κB probe.  
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Figure 3.2.4. NF-κB activation induced by C. albicans hyphae is not BTK-dependent. 
Wild- type BMDMs were preincubated for 30 min with DMSO or 25 and 50µM BTK 
inhibitor LFM-A13, followed by stimulation with hyphae for 90 min. and IκB degradation 
and IKKα/β activation were examined with anti-IκB and anti-phospho IKKα (Ser176)/ 
IKKβ(Ser180) antibodies. WT and PLCγ2-/- BMDMs were either non-treated or treated with 
C. albicans hyphae for 90 min and nuclear extracts were evaluated for NF-κB DNA-binding 
activity by electrophoretic mobility shift assay. OCT-1 DNA binding was used as a loading 
control.  
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Figure 3.2.5. PLCγ2 but not CARD9 mediates IKKα/β  phosphorylation. 
WT, CARD9-/-, and PLCγ2-/- BMDMs were stimulated with C. albicans hyphae for the 
indicated time points, and IKKα/β phosphorylation was examined using anti-phospho-
IKKα/β (Ser176/180) antibody. 
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Figure 3.2.6. PLCγ2 does not mediate CARD9-BCL10 association. WT and PLCγ2-
deficient BMDMs were stimulated with C. albicans hyphae (MOI: 1) for the indicated time 
points, and the cell lysates were immunoprecipitated with CARD9 antibody-conjugated 
agarose. The immunoprecipitates were probed with BCL10 and CARD9 antibodies. IP, 
immunoprecipitation; IB, immunoblot. 
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3.2.3 PLCγ2 regulates MAPK signaling in response to C. albicans yeast and hyphae 
 
Previous studies performed on dendritic cells demonstrate that C. albicans induces 
the activation of MAPKs to induce cytokine production (97). We examined how PLCγ2 
regulates MAPK activation in macrophages in response to C. albicans.  In response to 
hyphae we found that PLCγ2-deficient macrophages were completely defective in ERK and 
JNK signaling (Figure 3.2.7). However, p38 and AKT were comparable between WT and 
PLCγ2-/- macrophages (Figure 3.2.7).  In response to yeast JNK activation was significantly 
decreased in PLCγ2-/- macrophages, whereas ERK activation was only partially defective 
(Figure 3.2.8). These results suggest that in response to hyphae ERK activation depends 
solely on PLCγ2 whereas in response to yeast, two pathways mediate ERK activation. 
 
3.2.4. PLCγ1 in macrophages is not required for C. albicans-induced MAPK and NF-
κB activation 
 
We also investigated the role of PLCγ1, the homolog of PLCγ2 in antifungal 
immunity. PLCγ1 is also expressed in hematopoietic cells and has been shown to play a 
major role in TCR signaling (151). The yeast cell wall extracts, curdlan and zymosan, that 
mainly contain β-glucans have been shown to activate PLCγ1 in dendritic cells (146, 147). 
Because PLCγ1-deficient mice are embryonic lethal, we used bone marrow derived 
macrophages from PLCγ1 conditional knockout mice (PLCγ1f/f/ Mx1-cre) and its control 
(PLCγ1f/+/ Mx1-cre). We stimulated these macrophages with hyphae, but in contrast to 
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PLCγ2-/- mice, PLCγ1-deficiency did not affect ERK and IKK activation (Figure 3.2.9). 
These data ruled out the role of PLCγ1 functioning downstream of the C-type lectin 
receptors.  
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Figure 3.2.7. PLCγ2-deficient BMDMs display defective MAPK activation.  
Wild-type and PLCγ2-deficient (PLCγ2-/-) BMDMs were stimulated with C. albicans 
hyphae (MOI: 1) for the indicated time points. The cell lysates were prepared and subjected 
to immunoblotting analysis using the indicated antibodies. 
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Figure 3.2.8. PLCγ2-deficient BMDMs display defective MAPK activation.  
Wild-type and PLCγ2-deficient (PLCγ2-/-) BMDMs were stimulated with C. albicans yeast 
(MOI: 5) for the indicated time points. The cell lysates were prepared from these cells and 
then subjected to immunoblotting analysis using the indicated antibodies. 
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Figure 3.2. 9. PLCγ1-deficient BMDMs are not defective in MAPK activation.  
BMDMs from Mx1-cre/PLCγ1fl/- and Mx1-cre/PLCγ1fl/fl mice were stimulated with C. 
albicans hyphae for the indicated time points. Cell lysates were prepared and subjected to 
Western blotting.  
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3.2.5 PLCγ2 is the main phospholipase required for C. albicans cytokine production 
 
We investigated the requirement of PLCγ homologues to regulate cytokine 
production in response to C. albicans. We compared the levels of cytokine production in 
response to the hyphal (Figure 3.2.10) and yeast (Figure 3.2.11) form of C. albicans in 
PLCγ2-deficient macrophages.  In PLCγ2-deficient BMDMs compared to WT macrophages 
there was a significant decrease in the levels of TNF-α, IL-10, IL-12p40, IL-6 production 
both in the yeast and hyphal forms of C. albicans.  
The homologue of PLCγ2, PLCγ1 is also expressed in macrophages. To determine a 
possible role for PLCγ1 in macrophage antifungal immunity, we evaluated the role of 
PLCγ1 in cytokine production in BMDMs in response to stimulation with C. albicans. 
PLCγ1-deficiency causes early embryonic lethality (94), therefore we used conditional Mx1- 
Cre PLCγ1-deficient mice which lack PLCγ1 only in the hematopoietic system. However, 
we found lack of PLCγ1 did not alter cytokine production in BMDMs after stimulation with 
C. albicans (Figure 3.2.12). Collectively these data indicate that PLCγ2 is the main 
phospholipase that is critical in mediating immune responses in macrophages to fungal 
infections. 
 
	  	  	   	  	  	  
	   50	  
 
 
Figure 3.2.10. PLCγ2 contributes to cytokine induction by C. albicans stimulation. 
BMDMs from WT (black bars) and PLCγ2-deficient (PLCγ2-/-, white bars) mice were 
stimulated overnight with C. albicans hyphae (MOI: 1). ELISA was used to measure the 
level of cytokines in these cultured media. The data are the means ± S.D. of triplicate wells 
and are representative of three independent experiments. 
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Figure 3.2.11. PLCγ2 contributes to cytokine induction by C. albicans stimulation. 
BMDMs from WT (black bars) and PLCγ2-deficient (PLCγ2-/-, white bars) mice were 
stimulated overnight with C. albicans heat-killed yeast (MOI: 5). ELISA was used to 
measure the level of cytokines in these cultured media. The data are the means ± S.D. of 
triplicate wells and are representative of three independent experiments. 
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Figure 3.2.12. PLCγ1 is not required for cytokine production by C. albicans yeast and 
hyphae. BMDMs from Mx1-cre/PLCγ1fl/+ mice (WT, black bars) and Mx1-cre/PLCγ1fl/fl 
mice (PLCγ1-/-, white bars) were stimulated overnight with hyphae (MOI: 1) or heat-killed 
C. albicans yeast (MOI: 5) ELISA was used to measure the level of cytokines in these 
cultured media. The data are the means ± S.D. of triplicate wells and are representative of 
three independent experiments. 
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3.2.6.  ROS production in macrophages in response to C. albicans is controlled by 
PLCγ2 
 
Reactive oxygen species (ROS) production is an important defense mechanism 
against fungal infections.  Experiments conducted using zymosan have pointed to the role of 
Syk in mediating ROS production (144). However, downstream of Syk, other signaling 
components that are involved in ROS production are not clear. PLCγ2 has been shown to 
mediate NADPH oxidase production in integrin-mediated adhesion in neutrophils (152).  
Based on these observations, we examined if PLCγ2 is involved in ROS production to C. 
albicans infection. We found that in response to hyphae PLCγ2-deficient macrophages in 
contrast to WT macrophages were unable to produce ROS (Figure 3.2.13). However, 
stimulation with phorbol myristate induced robust ROS production in both PLCγ2-deficient 
and WT macrophages (Figure 3.2.13).  In contrast to what we observed in PLCγ2-deficient 
macrophages, PLCγ1-/- did not show any defect in ROS production compared to WT 
macrophage (Figure 3.2.13). Collectively, these data indicate that PLCγ2 is critical for 
initiating ROS production to mount an effective anti-fungal immune response to C. albicans. 
 PLCγ2 induces inositol 1,4,5-triphosphate and diacylglycerol. These components 
can then increase levels of intracellular calcium and activate PKC.  Using a PKC inhibitor 
GF109203X and a calcium chelator Bapta AM, we examined how PLCγ2 induces ROS 
generation. We found that induction of ROS production primarily depends on PKC 
activation, since pretreatment of macrophages with the PKC inhibitor significantly inhibited 
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ROS production, whereas the calcium chelator was able to only cause a partial decrease in 
ROS production (Figure 3.2.13). 
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Figure 3.2.13. PLCγ2 is required for ROS production in response to C. albicans hyphae 
stimulation. A and B, ROS production in WT (black squares) or PLCγ2-deficient (white 
circles) BMDMs was measured by using a luminometer following the stimulation with C. 
albicans hyphae (A, MOI: 2) or phorbol myristate acetate (B, 100µM). C, ROS production in 
Mx1-cre/PLCγ1+/+ (WT, black squares) and Mx1-cre/PLCγ1 fl/fl (PLCγ1-/-, white circles) 
BMDMs was measured following the stimulation with hyphae (MOI: 2). Data are means ± 
SDs and are representative of at least three independent experiments.  RU, relative units. 
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Figure 3.2.14. Hyphae-induced ROS production is dependent on PKC.  
 
ROS production in WT BMDMs pretreated for 1 hr with 10μM Bapta-AM (white squares) 
or 5μM GF109203X (white circles) or DMSO (black squares) and then stimulated with 
hyphae (MOI: 2). Data are means ± SDs and are representative of at least three independent 
experiments. RU: relative units. 
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3.2.7 PLCγ  2 is critical for anti-fungal immunity in an in-vivo model of disseminated 
candidiasis 
 
Candida causes severe disseminated blood stream infections in patients with 
compromised immune systems such as patients undergoing chemotherapy or bone marrow 
transplants. Therefore, we examined whether PLCγ2-deficiency was sufficient to increase a 
host’s susceptibility to Candida in vivo. To rule out the influence that lack of PLCγ2 could 
cause in other organs other than the hematopoietic system, we generated PLCγ2-deficient 
bone marrow chimera mice by reconstituting γ -irradiated wild-type mice with bone marrow 
from PLCγ 2-/- mice.   
To generate an in vivo model of disseminated candidiasis we intravenously injected 
live C. albicans into PLCγ2-/- and WT control mice. Initially we injected 1x 106 Candida, 
which led to the rapid death (within 24 hrs) of PLCγ2-/- mice but not WT control mice. Next 
we examined a low dose of Candida (2x 105) for intravenous injections. With this dose, 
PLCγ2-/- mice were dead within 48 hrs; however, the WT mice were able to survive for more 
than 5 days (Figure 3.2.17). We evaluated the level of IL-6 cytokine in the sera from PLCγ2-
/- mice at different time points during infection. We found that the PLCγ2-/- chimera mice 
showed lower levels of IL-6 compared to WT controls (Figure 3.2.15. A).  To quantitatively 
assess the fungal burden in mice, we sacrificed mice 42 hours after i.v. infections with 
Candida  and collected lungs, livers, spleens and kidneys from these mice.  Serial dilutions 
from the homogenized organs of these mice were plated on yeast extract peptone dextrose 
agar plates in order to count fungal colonies.  Quantitative assessment of the fungal burden 
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in organs from PLCγ2-deficient mice showed that these mice have a significantly higher 
level of Candida compared to the WT control mice infected (Figure 3.2.15. B). Moreover, 
tissues section from the organs collected from infected mice stained with periodic acid-Shiff 
showed a significantly higher level of germinating hyphal C. albicans compared to WT mice 
(Figure 3.2.16).  These in vivo experimental results demonstrate that PLCγ2 is critical for 
innate antifungal immune responses. 
 
 
 
 
. 
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Figure 3.2.15. PLCγ2-deficient mice show higher susceptibility to C. albicans infection 
than WT mice. A, WT and PLCγ2-deficient mice (n =3) were challenged with C. albicans 
(2 x 105) intravenously, and serum samples from each mouse were tested for IL-6 levels by 
ELISA. The data are the means ± S.D. from triplicate samples. B, 42 h after intravenous 
infection with C. albicans (2 x 105), some of the infected mice were sacrificed. The liver, 
kidney, lung, and spleens from WT and PLCγ2-deficient mice (n=3) were homogenized, and 
serial dilutions of the homogenized organs were plated on yeast extract peptone dextrose 
agar plates to determine the yeast colony forming unit (CFU). The data are colony forming 
unit/organ weight. Data in panel A is generated through collaboration with Mei Yu and Dr. 
Demin Wang. Data in panel B is courtesy of Mei Yu and Dr. Demin Wang.  
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Figure 3.2.16. The histopathology of kidney, lung, spleen, and liver from wild-type and 
PLCγ2-/- mice after C. albicans infection.  
The liver, kidney, lung, and spleens of WT and PLCγ2-deficient mice at 42 hours after i.v. 
infection with C. albicans (2x105 cells) were collected. The tissue slides of these organs 
were stained with hematoxylin and eosin or PAS. Data is generated through collaboration 
with Mei Yu and Dr. Demin Wang. 
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Figure 3.2.17. PLCγ2-deficient mice show higher susceptibility to C. albicans infection 
than WT mice.  WT and PLCγ2-deficient mice were challenged with C. albicans (2 x105) 
intravenously and monitored every day for lethality. Data is courtesy of Mei Yu and Dr. 
Demin Wang. 
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3.3 Discussion 
 
In the C-type lectin receptor signaling pathway, the kinase Syk and the adaptor 
protein CARD9 are important signaling components for these receptors. But the mechanism 
of how these proteins link the receptor signaling to NF-κB and MAPK cascades was not 
defined. In our study, we provide strong evidence that PLCγ2 is the essential PLCγ isoform 
mediating the signaling cascades downstream of the Dectin-2 receptor. In our study, we 
demonstrate that NF-κB activation in response to C. albicans is not mediated through TLR 
signaling because we could not detect any difference in NF-κB activation levels between 
WT and MyD88 deficient macrophages. Previous studies have indicated that TLR signaling 
collaborated with the Dectin-1 receptor (52, 148).  In these studies zymosan, the extract 
from the yeast cell wall S. cerevisiae was used as a ligand for Dectin-1 receptor to measure 
cytokine production. While NF-κB activation measured by EMSA was similar between 
MyD88-deficient and WT macrophages, we observed a significant decrease of NF-κB 
activation in PLCγ2-deficient macrophages stimulated by C. albicans. This study indicates 
differences between using the whole fungal organism versus cell wall extracts. Another 
interesting observation in our studies is the mechanisms regulating the activation of the IKK 
complex in response to fungal infections. The IKK complex is activated by the 
phosphorylation of the IKKα/β subunits alongside the K63 ubiquitination of IKKγ subunit. 
Studies from our lab have shown that the adaptor protein CARD9 regulates the 
ubiquitination of IKKγ whereas the kinase Syk is essential for IKKα/β phosphorylation 
events (62). In this study we show that PLCγ2 regulates the phosphorylation of IKKα/β 
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whereas we do not observe this decrease in phosphorylation levels in CARD9-deficient 
macrophages. Furthermore, lack of PLCγ2 did not affect the association of CARD9 with its 
binding partner BCL10. However, it still remains to be determined if PLCγ2 regulates IKKγ 
ubiquitination. Collectively these observations indicate that CARD9 and PLCγ2 are 
activating the IKK complex in an independent manner.  
The production of reactive oxygen species is followed by the phagocytosis of C. 
albicans (53). Syk mediates ROS production but not phagocytosis of fungus (144). The 
adaptor protein CARD9 also regulates ROS production but only partially (137).  In our 
study, we demonstrate that PLCγ2 mediates ROS production in macrophages.  Although the 
exact mechanism that links ROS production to PLCγ2 is not clear, we provide evidence that 
PKC family members regulate ROS production since ROS production was decreased with 
the use of a PKC inhibitor but not the calcium chelator. In dendritic cells ROS production is 
thought to mediate inflammasome activation (153). Future studies are needed to determine if 
PLCγ2 is required for inflammasome activation. 
In our study ERK activation induced by yeast stimulation was only partially reduced 
in PLCγ2-deficient cells; however, ERK activation induced by hyphae stimulation was 
undetectable. This finding suggests that in response to yeast, ERK activation is mediated 
through additional pathways that do not require PLCγ2. The Grb2-SOS-Ras-Raf1 signaling 
pathway can also mediate ERK activation. In this pathway SOS, which is a Ras guanine 
nucleotide exchange factor, can be recruited to the membrane by Grb2. These events can 
lead to the activation of Ras, which then by activating Raf-1 will lead to ERK1 and ERK2 
kinase activation (154, 155).  Our study points to the possibility that C. albicans yeast form 
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may utilize the Grb2/ Ras/ Raf1 signaling pathway, which in part may help explain the 
partial reduction that we observe in ERK activation. 
For many patients with hematological malignancies, chemotherapy and stem cell 
transplantation are currently the only treatment options. These treatments damage immune 
barriers, rendering these patients to infections. Future studies to investigate possible 
polymorphisms in the PLCγ2 gene in stem cell transplant recipients could improve 
individualized risk-assessments for fungal infection and aide in new antifungal prophylaxis 
strategies. 
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Chapter 4 
 
TAK1 plays an essential role in anti-fungal immunity 
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Chapter 4: TAK1 plays an essential role in anti-fungal immunity 
 
 
4.1. Background 
 
 
Transforming growth factor-β activated kinase-1 (TAK1) is a member of the 
mitogen-activated protein kinase kinase kinase (MAP3K) family, which plays a pivotal role 
in adaptive and innate immune signaling (156, 157). TAK1 is activated by a diverse range of 
stimuli such as ligands for Toll-like receptors, tumor necrosis factor receptor (TNFR) and 
IL-1 receptor that can lead to the activation of NF-κB and MAPK signaling pathways (158). 
TAK1 binding protein TAB2 and TAB3 can recruit TAK1 to polyubiquitin chains (159, 
160). TAB2 germ-line knockouts are embryonic lethal and deficiency in TAB2 can decrease 
NF-κB activation (161, 162). Thus, it has been proposed that TAB2 and TAB3 may have 
some level of redundancy. The in vivo tissue specific roles of these proteins remain to be 
determined. 
TAK1 knockout mice are embryonic lethal (163) and deletion of TAK1 in the 
hematopoietic system leads to uncontrolled apoptosis of hematopoietic stem cells (164).  
Therefore studies investigating the role of TAK1 in hematopoietic cells have been 
conducted by using conditional knockouts in a specific lineage. T cell specific TAK1- 
deficient mice display defects in thymocyte development and in the activation of JNK and 
NF-κB signaling pathways (165, 166). In the B cell receptor signaling pathway TAK1 only 
mediates JNK activation (167).  
In non-innate immune cells such as embryonic fibroblast and B cells, TAK1 can 
mediate NF-κB and AP-1 activation upon TLR stimulation (167, 168). Recently the role of 
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TAK1 in TLR signaling in myeloid cells was investigated. The generation of myeloid-
specific TAK1-deficient mice has produced somewhat contradictory phenotypes. In one 
report myeloid-specific TAK1-deficiency did not affect the ability of myeloid precursors to 
differentiate into macrophages and granulocytes. In addition TAK1-deficiency in 
macrophages caused impairment in JNK and NF-κB activation in response to LPS 
stimulation. Furthermore, LPS stimulation caused an increase in IL-1β, TNF-α and IL-6 in 
TAK1-deficient macrophages compared to WT (169). In a separate mouse model of 
myeloid-specific TAK1-deficiency, BMDMs from TAK1-deficient mice died after culturing 
for 3 days in conditional media containing M-CSF due to apoptosis (170). Compared to WT 
controls, TAK1-deficient peritoneal macrophages in this mouse model did not show a defect 
in JNK and NF-κB activation in response to LPS stimulation. 
In TLR signaling the adaptor molecule MyD88 activates the Tumor necrosis factor 
receptor-associated factor 6 (TRAF6), which contains E3 ubiquitin ligase activity. In 
response to various stimuli including TLR ligands, IL-1 and RANK ligand, TRAF6 interacts 
with TAK1 through the TAK1-associating protein TAB2 (171-173). In the TCR pathway it 
has been implicated that TRAF6 and TAK1 can mediate IKK activation through BCL10 and 
MALT1 (95). However, TRAF6 knockout mice do not show any defects in T cell activation 
(174, 175). Therefore, it has been speculated that TRAF2 may compensate for the lack of 
TRAF6 in T cells. A recent study using B cell specific TRAF6 knockout mice showed a role 
for TRAF6 in mediating classical NF-κB and MAPK activation in response to TLR and 
CD40 receptor stimulation (176). Similar to previous reports (170), we observed that 
myeloid-specific TAK1-deficient mice could not develop macrophages from bone marrow. 
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In collaboration with Dr. Bryant Darnay in the Department of Experimental Therapeutics at 
The University of Texas MD Anderson Cancer Center in Houston, we used myeloid-specific 
TAK1-deficient mice crossed with TNFR1-deficient mice, which were generated in Dr. 
Darnay’s laboratory, to rescue the BMDM developmental defect observed in myeloid 
TAK1-deficient mice. In this study we were interested in understanding the role of TAK1 
and TRAF6 in mediating immunity against the opportunistic fungus Candida albicans. The 
mechanisms controlling C-type lectin receptor signaling in response to fungal infections are 
not well understood. In this work, we report that in macrophages TAK1 and TRAF6 are 
essential for mediating anti-fungal immunity by regulating NF-κB and MAPK signaling and 
regulating proinflammatory cytokine production. 
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4.2. RESULTS 
 
4.2.1 TAK1 is essential for NF-κB, JNK and p38 activation in response to Candida 
albicans 
Our previous study demonstrated that phospholipase γ2 (PLCγ2) was an essential 
component for NF-κB and MAPK activation in response to C. albicans (177). NF-κB 
activation induced by C. albicans is not mediated through MyD88 because we could not 
detect any difference in NF-κB activation in MyD88-deficient macrophages compared to 
WT in response to C. albicans stimulation.  
To examine the possible role of TAK1 in mediating anti-fungal immunity, we 
investigated the activation of the NF-κB pathway in TAK1-deficient mice. By evaluating the 
DNA-binding activity of NF-κB transcription factor (Figure 4.2.1), we found that in 
response to both the yeast and hyphal form of C. albicans, NF-κB activation was defective 
in TAK1-deficient mice compared to TNFR1-deficient or WT mice. Furthermore, in TAK1- 
deficient mice we demonstrate that the defect in NF-κB activity is due to the absence of 
phosphorylation of IKKα/β subunits of the IKK complex  (Figure 4.2.1). Since TAK1 is 
suggested to regulate the MAPKs we determined the role of TAK1 in mediating JNK and 
p38 activation. TAK1-deficient mice compared to TNFR1- deficient or WT mice showed a 
decrease in JNK and p38 activation in response to Candida hyphae (Figure 4.2.2). 
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Figure 4.2.1.  NF-κB activation induced by C. albicans hyphae and yeast is TAK1-
dependent. (A) WT, TNFR1-deficient and TNFR1-/-TAK1-/- BMDMs were either untreated 
or treated with C. albicans hyphae (MOI: 1) or heat-inactivated yeast (MOI: 5) for 90 min. 
The nuclear extracts were prepared from these cells and then subjected to the electrophoretic 
mobility shift assay using 32P-labeled NF-κB or OCT-1 probe. (B) WT, TNFR1-deficient 
and TNFR1-/-TAK1-/- BMDMs were stimulated with C. albicans hyphae for the indicated 
time points, and IKKα/β phosphorylation was examined using anti-phospho-IKKα (Ser-
176)/IKK-β (Ser-180) antibody. 
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Figure 4.2.2. TAK1-deficient BMDMs display defective MAPK activation.  
WT, TNFR1-/-, TNFR1-/-TAK1-/- BMDMs were stimulated with C. albicans hyphae for the 
indicated time points. Cell lysates were prepared from these cells and then subjected to 
Western blotting.  
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4.2.2. TAK1 regulates cytokines necessary for T helper differentiation in response to 
Candida albicans 
 
To determine if TAK1-deficiency can regulate the production of cytokines important 
in inducing an adaptive immune response to fungal infections, we evaluated the levels of IL-
6, IL-12 and TNF-α in TAK1/TNFR1-deficient mice compared to TNFR1-/- and WT 
macrophages. As shown in (Figure 4.2.3) TAK1-deficiency caused a decrease in 
proinflammatory cytokine production compared to TNFR1-/- and WT mice. The cytokine IL-
1β plays an important role in the differentiation of Th17 cells.  In contrast to dendritic cells 
IL-1β production in macrophages is a two-step process. Stimulation of macrophages with 
hyphae alone cannot induce detectible levels of IL-1β (Figure 4.2.4). Priming of cells with 
zymosan prior to stimulation with hyphae is a necessary step to induce IL-1β production 
(Figure 4.2.4).  We investigated the levels of IL-1β production in TAK1/ TNFR1-deficient 
cells compared to TNFR1 and WT macrophages. Compared to WT macrophages, TNFR1- 
deficient macrophages showed lower levels of IL-1β production (Figure 4.2.4). However, 
TAK1/TNFR1-deficient macrophages demonstrated a lower level of IL-1β production 
compared to TNFR1-deficient (Figure 4.2.4), which demonstrates an essential role for 
TAK1 in IL-1β production.   
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Figure 4.2.3. TAK1 contributes to cytokine induction by C. albicans stimulation. 
BMDMs from WT (black bars), TNFR1-deficient (lined bars), TNFR1-/-TAK1-/- (white 
bars) mice were stimulated overnight with C. albicans hyphae (MOI: 1). ELISA was used to 
measure the level of cytokines in these cultured media. The data are the means ± S.D. of 
triplicate wells and are representative of three independent experiments. 
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Figure 4.2.4. TAK1 contributes to cytokine induction by C. albicans stimulation.  
A) BMDMs from WT (white bars) were primed with either LPS or zymosan then left 
untreated or stimulated with live hyphae or paraformaldehyde fixed hyphae for overnight.  
ELISA was used to measure the level of cytokines in these cultured media. B) WT (black 
bars) TNFR1-deficient (lined bars) and TNFR1-/-TAK1-/- (white bars) mice were primed 
with zymosan with or without live C. albicans hyphae (MOI: 1) for overnight. ELISA was 
used to measure the level of cytokines in these cultured media. C) TNFR1-deficient (white 
bars) and TNFR1-/-TAK1-/- (black bars) were primed with zymosan with or without live C. 
albicans hyphae (MOI: 1) for overnight. ELISA was used to measure the level of cytokines 
in the media. The data are the means ± S.D. of triplicate wells and are representative of three 
independent experiments. 
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4.2.3 TRAF6 is crucial for C. albicans mediated NF-κB and JNK activation 
 
Tumor necrosis factor receptor-associated factor 6 (TRAF6) can form a complex 
with TAK1 in response to receptor activator of NF-κB ligand (RANKL) stimulation (171). 
In the interleukin-1 signaling pathways TRAF6 and TAK1 can form a complex that is 
mediated by TAB2 (172), leading to IKK and MAPK activation. To investigate if TRAF6 is 
mediating proinflammatory responses to Candida infections we evaluated NF-κB activation 
in TRAF6-deficient macrophages in response to hyphae. TRAF6-deficient macrophages 
showed a decrease in the DNA-binding activity of NF-κB transcription factor and were 
defective in the degradation of IκB compared to WT mice (Figure 4.2.5). However, in 
contrast to what we showed in TAK1-deficient macrophages, we could not detect any 
difference in the levels of IKKα/β phosphorylation between TRAF6-deficient wild-type 
mice (Figure 4.2.6). We next examined how TRAF6-deficiency would impact MAPK 
activation. In response to hyphae, TRAF6-/- macrophages showed a decrease in JNK but not 
ERK activation when compared to WT macrophages (Figure 4.2.6). To examine the role of 
TRAF6 in antifungal immunity we evaluated the levels of proinflammatory cytokines IL-6 
and IL-12 in response to hyphae. Indeed, TRAF6-/- macrophages were defective in the 
production of IL-6 and IL-12 cytokines (Figure 4.2.7), indicating a role for TRAF6 in 
mediating anti-fungal immune responses. To determine how TRAF6 is regulating NF-κB 
activation we found that upon hyphae stimulation TRAF6 becomes ubiquitinated (Figure 
4.2.8). In addition we find that in BMDMs TRAF6 binds to BCL10 and TAK1 (Figure 
4.2.8). Although TRAF6 binds BCL10 constitutively it appears that the complex formation 
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of TAK1 and TRAF6 is inducible. Therefore, we conclude that Traf6 mediates antifungal 
immunity by regulating NF-κB and JNK signaling pathways that are crucial for 
proinflammatory cytokine production. 
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Figure 4.2. 5. NF-κB activation induced by C. albicans hyphae is TRAF6-dependent. 
 
 (A) WT and TRAF6-deficient BMDMs were either untreated or treated with C. albicans 
hyphae (MOI: 1) for 90 min. The nuclear extracts were prepared from these cells and then 
subjected to the electrophoretic mobility shift assay using 32P-labeled NF-κB or OCT-1 
probe. (B) WT and TRAF6-deficient BMDMs were stimulated with C. albicans hyphae for 
the indicated time points, and IκB-α was examined using the indicated antibody. 
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Figure 4.2.6.  TRAF6 contributes to JNK but not IKKα/β  phosphorylation. 
WT and TRAF6-deficient BMDMs were either untreated or treated with C. albicans hyphae 
(MOI: 1) for the indicated time points, and phosphorylation was examined using the 
indicated antibodies. 
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Figure 4.2.7. TRAF6 contributes to cytokine induction by C. albicans stimulation. 
 BMDMs from Heterozygous (white bars) and TRAF6-deficient (black bars) mice were 
stimulated overnight with C. albicans hyphae (MOI: 1). ELISA was used to measure the 
level of cytokines in these cultured media. The data are the means ± S.D. of triplicate wells 
and are representative of three independent experiments. 
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Figure 4.2.8. TRAF6 is ubiquitinated upon C. albicans stimulation and forms a 
complex with BCL10 and TAK1. 
 
WT BMDMs were stimulated with C. albicans hyphae (MOI: 1) for the indicated time 
points, and the cell lysates were immunoprecipitated with TRAF6 antibody-conjugated 
agarose. The immunoprecipitates were probed with the indicated antibodies. IP, 
immunoprecipitation; WCL, whole cell lysate. 
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4.2.4. TRAF6 is not required for hyphae induced reactive oxygen species production. 
 
Reactive oxygen species (ROS) are a critical component of the immune system to 
fight against pathogens. Previous studies in bone marrow derived monocytes show that 
RANK ligand stimulation can generate reactive oxygen species production. The ROS 
production in these cells was dependent on TRAF6 since TRAF6-deficient osteoclast 
precursors had significantly reduced levels of ROS production compared to WT (178). To 
examine the importance of TRAF6 in C. albicans hyphae induced ROS production, we 
compared ROS production in TRAF6-deficient BMDMs and wild-type cells. The level of 
ROS production by hyphae was similar in TRAF6- null BMDMs compared to wild-type 
(Figure 4.2.9), which indicates that C. albicans induced ROS production in macrophages is 
not dependent on TRAF6. 
 
4.2.5. CYLD is not involved in antifungal immunity 
 
The deubiquitase CYLD can regulate TAK1 activation by inhibiting autoactivation 
and ubiquitination by physically interacting with TAK1 in T cells (179). Therefore we 
hypothesized that CYLD may regulate antifungal immunity by regulating TAK1. We 
examined the DNA-binding activity of NF-κB transcription factor in response to C. albicans 
yeast and hyphae in WT and CYLD-deficient macrophages. However, we could not detect 
any difference in NF-κB activation or in TNF-α cytokine production between CYLD- 
deficient and WT macrophages (Figure 10). In addition CYLD-/- and WT macrophages were 
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comparable in the levels of JNK and ERK activation in response to C. albicans yeast and 
hyphae (Figure 4.2.11).  These results suggest that CYLD does not regulate C-type lectin 
receptor signaling in macrophages. 
 
. 
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Figure 4.2.9. TRAF6 is not required for ROS production in response to C. albicans 
hyphae stimulation. ROS production in heterozygous (black squares) or TRAF6-deficient 
(white squares) BMDMs was measured by using a luminometer following the stimulation 
with C. albicans hyphae (MOI: 2). Data are means and are representative of at least three 
independent experiments. RU, relative units. 
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Figure 4.2.10. CYLD does not contribute to NF-κB activation or TNF cytokine 
induction by C. albicans stimulation. A) WT and CYLD-deficient BMDMs were either 
untreated or treated with C. albicans hyphae (MOI: 1) for 90 min. The nuclear extracts were 
prepared from these cells and then subjected to the electrophoretic mobility shift assay using 
32P-labeled NF-κB or OCT-1 probe. B) Enzyme-linked immunosorbent assay of TNF in the 
supernatants from BMDMs of WT (white bars) and CYLD-deficient (black bars) mice that 
were stimulated overnight with C. albicans hyphae (MOI: 1) or heat- killed yeast (MOI: 5).   
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Figure 4.2.11. CYLD-deficient BMDMs are not defective in MAPK activation in 
response to C. albicans. Wild-type and CYLD-deficient (CYLD-/-) BMDMs were 
stimulated with C.albicans hyphae (MOI: 1) or heat- killed yeast (MOI: 5) for the indicated 
time points. The cell lysates were prepared from these cells and then subjected to 
immunoblotting analysis using the indicated antibodies. 
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4. 3. Discussion 
 
In this study we demonstrate an important role for TAK1 in mediating antifungal 
immunity.  We report that in response to both the yeast and the hyphal form of C. albicans 
TAK1/TNFR1-/- macrophages are defective in NF-κB activation compared to TNFR1-/- and 
WT macrophages. Furthermore, we show that TAK1-deficiency causes a decrease in JNK 
and p38 activation. Collectively, this reduction in NF-κB and MAPK signaling cascades is 
leading to decreased levels of TNF, IL-6, IL-12 and IL-1β cytokine production in TAK1-/-
/TNFR1-/- macrophages compared to WT and TNFR1-/- macrophages. Studies using mice 
with specific deletion of TAK1 in the myeloid lineage demonstrate that loss of TAK1 
promotes macrophage apoptosis and increases the proliferation of neutrophils (170). 
Experiments performed with peritoneal macrophages from these mice demonstrated that 
TAK1-deficiency did not affect NF-κB or MAPK activation in response to LPS stimulation. 
However, in neutrophils loss of TAK1 caused an increase in NF-κB and MAPK activation 
in response to LPS stimulation (170). Collectively, these results demonstrate the cell type-
specificity of TAK1 in regulating the innate immune response to bacterial versus fungal 
pathogens. In addition, we find that in macrophages TRAF6-deficiency causes a decrease in 
NF-κB and JNK activation. We demonstrate the mechanism that TAK1 and TRAF6 use to 
activate the IKK complex in response to C. albicans stimulation differs.   
 Previous observations show a critical role for TRAF6 in TLR and CD40 receptor 
signaling (180). Our findings together with previous studies using TRAF6-deficient cells 
indicate that TRAF6 in an important signaling component in myeloid cells that converges 
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signals both from TLR and C-type lectin receptors. How TAK1 is activated in response to 
fungal stimuli remains to be elucidated. Previous studies suggest that TAK1 undergoes 
autophosphorylation (181, 182). One possibility is that the complex of TRAF6-TAB2-TAK1 
may cause a conformational change in TAK1, thus promoting TAK1 kinase activity. 
Although it is proposed that TAK1 is the upstream kinase that phosphorylates the IKK 
complex, the mechanistic details of IKK activation is not fully elucidated. We show that 
TAK1-deficiency causes a defect in the phosphorylation of the IKK complex. Recently it 
was shown that TAK1 phosphorylation is mediated by CARD9 (183). However, we did not 
observe any difference in the phosphorylation of IKKα/β in CARD9-deficient mice 
compared to WT mice. This observation is similar to what has been reported in CARMA1-
deficient T cells, which do not show any defect in IKKα/β phosphorylation in response to 
TCR stimulation compared to wild-type T cells (150). Based on our experimental results we 
propose that TRAF6 is important in linking the CARD9-BCL10 complex to the 
ubiquitination of IKKγ. Furthermore, TRAF6 polyubiquitination recruits TAK1 leading to 
its possible autophosphorylation and consequently the phosphorylation of IKKα/β subunits 
in response to C. albicans. 
Pharmacological inhibition or gene mutations that cause the inactivation of NF-κB is 
reported to sensitize cells to TNF-α-induced apoptosis (184). However, adoptive transfer of 
NF-κB-deficient fetal liver cells does not affect the survival of hematopoietic stem cells or 
myeloid lineage cells (185) suggesting that NF-κB signaling alone is not responsible for 
myeloid cell survival. Reactive oxygen species levels in cells can also affect cell survival. 
Although TRAF6-deficiency has been shown to promote TNF-induced cell death and 
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accumulation of reactive oxygen species (186), we did not observe a defect in macrophage 
differentiation or hyphae-induced reactive oxygen species production using TRAF6-
deficient mice. In our studies we did not determine reactive oxygen species levels in TAK1-
deficient macrophages. One possibility is that TAK1-deficient macrophage precursors are 
highly sensitive to TNF-induced ROS accumulation. TAK1-deficient neutrophils are 
reported to produce higher levels of ROS compared to WT cells in response to LPS 
treatment (170). Quantitative differences in signaling molecules expression levels may affect 
cell type specific development. For example, in myeloid precursors a high level of c-Src 
expression affects osteoclast, but not macrophage or dendritic cell development (187). 
Microarray analysis of TAK1-deficient macrophages compared to TNFR1-deficient 
macrophages may help in identifying key components for macrophage cell survival.  
The TAK1-binding proteins (TAB), TAB2 and TAB3 are required for TAK1 
activation (159). In the IL-1, RANKL, TNF signaling pathways the functional interaction 
between TAK1 and TAB2/ TAB3 is crucial for mediating IKK and MAPK signaling (188). 
Further studies will be needed to investigate if TAB2 and TAB3 mediate C-type lectin 
receptor signaling and whether or not TAB2 and TAB3 play redundant functions in immune 
signaling. 
Previous studies report that in response to bacteria TRAF6-depleted macrophages 
showed a decrease in the levels of mitochondrial ROS production, which impaired the 
ability of these mice to effectively kill intracellular bacteria (189). In our studies we could 
not detect any difference in NADPH mediated reactive oxygen species production upon 
stimulation with C. albicans hyphae between TRAF6-deficient and WT BMDMs. Whether 
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in macrophages C. albicans stimulation can trigger mitochondrial ROS production in a 
TRAF6 dependent manner is a topic of future investigation. 
In this study we investigated the role of CYLD in mediating macrophages immune 
response to C. albicans. However, we could not detect any difference between CYLD-
deficient macrophages and WT in the activation of MAPKs, NF-κB or in cytokine 
production upon C. albicans stimulation.  In lymphocytes, CYLD has an important role in 
regulating TCR signaling (179, 190) and negatively regulating NF-κB signaling in B cells 
(191). However, studies using CYLD-deficient macrophages show undetectable to moderate 
changes in NF-κB activation in response to TNFR or TLR signaling (190, 192). Our 
findings together with previous studies indicate that CYLD is not critical in regulating 
pattern recognition receptor signaling in macrophages. The ubiquitin-modifying enzyme 
A20 is crucial in terminating TLR responses and can be inducibly expressed by these cells 
(193). Therefore, it is possible that in pattern recognition receptor signaling, CYLD plays a 
redundant role with A20. 
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Chapter 5: Identification of CARD9 binding partners 
 
 
5.1. Background 
 
 The adaptor protein CARD is an important signaling component downstream of C-
type lectin receptors and is necessary to mediate anti-fungal immunity (62, 68, 100, 194). 
CARD9 was identified by a database search for CARD-containing proteins and can form a 
complex with BCL10 and MALT1 to mediate downstream NF-κB activation (98). CARD9 
protein structure consists of a C-terminus coiled-coil domain and a N-terminus CARD 
domain and is primarily expressed in myeloid lineage cells (98, 100). CARD9 does not 
contain a PDZ domain. The PDZ domain in CARD-containing membrane-associated 
guanylate kinase (CARMA) family members is critical for these proteins to associate to the 
plasma membrane (98). CARD9 regulates NF-κB activation by regulating the IKK complex 
(62). Both Syk and CARD9 are required for the activation of the IKK complex. Syk is 
required for the phosphorylation of IKKα/β subunits, whereas CARD9 regulates the 
ubiquitination of IKKγ (62). The signaling components that link Syk to CARD9 activation 
are not well understood. In this study, we were interested in indentifying novel protein 
binding partners for CARD9 to help elucidate the C-type lectin receptor signaling pathways. 
 
5.2. Results 
 
To identify CARD9 binding partners we chose to use the SILAC method (12). 
SILAC is a method for metabolic labeling in which the quantitative tags used for 
measurements in mass spectrometry are incorporated into the cells through cell culturing. In 
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this method we can minimize experimental artifacts and variations that are often 
encountered by processing each sample individually (16-18). To minimize non-specific 
proteins that will immunoprecipitate will our protein of interest we constructed a double-
tagged vector for CARD9 containing the FLAG and HA vectors. We overexpressed FLAG-
CARD9-HA vector in 293T cells and performed a tandem immunoprecipitation. We first 
immunoprecipitated our 293T cell lysate with FLAG beads. Following an elution with 
FLAG peptide we performed a second IP using HA beads. We ran the denatured 
immunoprecipitates on an SDS PAGE gel and stained the gel by silver-staining method.  As 
shown in Figure 5.2.1 we found that tandem immunoprecipitation greatly reduced the 
background of non-specific bands visualized in our initial single immunoprecipitations 
experiments (data not shown) and that in this overexpression system the strong CARD9 
band corresponded to the correct size of CARD9. 
C-type lectin receptors and CARD9 are primarily expressed in myeloid cells 
therefore we stably transfected the RAW 264.7 cell line to express FLAG-CARD9-HA or 
the empty vector. The RAW 264.7 cell line expressing FLAG-CARD9-HA was divided into 
two portions. One group was cultured in DMEM media depleted of normal lysine and 
supplemented with lysine D4 whereas the other portion was cultured in DMEM media 
depleted of normal lysine and supplemented with lysine 13C615N2. The RAW 264.7 cell line 
stably expressing the emptor vector was cultured in lysine depleted DMEM supplemented 
with lysine. These cells were passaged at least five times to efficiently label the cells. We 
used the RAW 264.7 cell line expressing FLAG-CARD9-HA labeled with lysine 13C615N2   
and stimulated this cell line with C. albicans. Using the same cell number we made cell 
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lysates from all three RAW 264.7 cell lines cultured in different labeling conditions. We 
then combined these lysates and immunoprecipitaed using FLAG beads overnight. After 
several washes we eluted CARD9 from the beads by incubating the FLAG beads with 
elution buffer for thirty minutes then collecting the flow-through from the columns. We 
combined the eluted proteins and performed a second immunoprecipitation using HA beads. 
After several washes we boiled the beads and ran the immunoprecipitate on a SDS-PAGE 
gel and stained the gel with sypro ruby staining.  We observed various bands on the gel and 
we cut the gel into ten different sections (Figure 5.2.4 A). Each band was analyzed by mass 
spectrometry to determine the immunoprecipitated proteins and to compare the ratio for 
different isotopes of lysine. Although we did successfully detect CARD9 as one of the 
proteins identified in the mass spectrometry results (Table 5.2.2) we could not detect any 
specific potential binding partner since the ratio for the normal lysine was higher as shown 
for example in the two proteins Myh9 and Actb (Table 5.2.2). In an independent experiment, 
when comparing unstimulated Raw 264.7 cell line expressing FLAG-CARD9-HA to the 
Raw 264.7 cell line expressing the empty vector, we identified CARMA1 as a potential 
binding partner. CARMA1 received a high peptide hit, which validated the protein 
identification in mass spectrometry (Table 5.2.3). We further validated the binding of 
CARMA1 to CARD9 by western blots (Figure 5.2.4. B). However, CARMA1 has no known 
role in ITAM-associated receptor signaling in myeloid cells and CARMA1-deficient 
macrophages do not show any defect in NF-κB activation in response to both the yeast and 
hyphal form of C. albicans (Figure 5.2.5). 
 
	  	  	   	  	  	  
	   94	  
  
 
 
 
 
 
 
 
Figure 5.2.1. Silver staining of CARD9-FLAG-HA in 293Tcells.  293T cells were 
transiently transfected with a FLAG-CARD9-HA construct or an empty vector.  The cell 
lysates were tandem immunoprecipitated by FLAG-conjugated and HA-conjugated beads 
respectively. The immunoprecipitates were loaded onto a SDS-PAGE gel and silver stained. 
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Table 5.2.2. Mass spectrometry analysis of CARD9 binding partners.  
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Table 5.2.2. Continued 
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Table 5.2.3. Protein identification of CARD9 binding partners by mass spectrometry 
analysis. 
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Figure 5.2.4. CARMA1 constitutively binds to CARD9 
 
 A. Cell lysates from RAW 264.7 cell line stably expressing a FLAG-CARD9-HA 
(stimulated with C. albicans or left untreated) was mixed with an equal protein quantity 
from cell lysates of RAW 264.7 stably expressing the empty vector. The cell lysates were 
tandem immunoprecipitated with FLAG and HA conjugated beads respectively. The 
immunoprecipitates were run on a SDS-PAGE gel and stained by Sypro Ruby. B. Cell 
lysates from RAW 264.7 cell line stably expressing a FLAG-CARD9-HA construct was 
immunoprecipitated with Flag-conjugated or IgG-conjugated agarose. The 
immunoprecipitates were probed with CARMA1 or FLAG antibodies. IP, 
immunoprecipitation; IB, immunoblot. 
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Figure 5.2.5. NF-κB activation induced by C. albicans hyphae and yeast is not 
CARMA1 dependent. 
 WT and CARMA1-deficient BMDMs were either untreated or treated with C. albicans 
hyphae (MOI: 1) or heat-inactivated yeast (MOI: 5) for 90 min. The nuclear extracts were 
prepared from these cells and then subjected to the electrophoretic mobility shift assay using 
32P-labeled NF-κB or OCT-1 probe. 
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5.3. Discussion  
 
Most cell signaling cascades involve the regulation of multiprotein complexes. The 
multiplex labeling method enables us to compare different cell populations using a single 
experiment, improving the efficiency and accuracy in quantitative proteomics. Protein 
functions such as catalytic activity or specificity to substrates are regulated by polypeptides 
in a holoenzyme complex. In this scenario protein binding partners might be present in 
amounts that are not stoichiometric (195, 196). This property of proteins poses a problem in 
indentifying specific binding partners that are expressed at low levels from a vast number of 
highly expressed but low affinity non-specific binding proteins that are identified in 
immunoprecipitation techniques. One simple solution for this problem would be to increase 
the stringency level of purification methods. The caveat of this route is that the probability 
of still being able to detect specific binding partners with low affinity will most likely be 
reduced. In this study, we chose to use the stable isotope labeling with amino acids in cell 
culture (SILAC) quantitative proteomics as a method to identity CARD9 binding partners. 
In our experimental design we had the opportunity to incorporate a negative control in our 
mass spectrometry analysis which would enable use to distinguish specific binding partners 
from non-specific background proteins without using harsh washing conditions. Our mass 
spectrometry results have identified a large number of proteins; however, when comparing 
the ratios of specific to non-specific binding proteins, CARD9 was the only specific protein 
detected. In a separate experiment we detected CARMA1 as a binding partner for CARD9 
but in this case the signal-to-background ratio was still close to background levels. 
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 CARMA1 is known to regulate ITAM- associated receptor induced NF-κB 
activation in lymphoid lineage cells (85). Currently, there is no known ITAM-associated 
receptor in myeloid lineage cells that utilizes CARMA1. Thus, the question remains why in 
myeloid lineage cells, CARD9 but not CARMA1 functions downstream of ITAM-associated 
receptors and if there is redundancy between CARMA1 and CARD9 in myeloid lineage 
cells. 
Immunoprecipitation and mass spectrometry has been the classical method for 
identifying protein-protein interactions and is proven to be quite successful in identifying the 
core interacting proteins. We speculate that CARD9-BCL10 is one of these core complexes. 
However, this does not rule out the possibility of other proteins interacting with CARD9 but 
with a detection threshold too low for mass spectrometry analysis.  Aside from BCL10, 
CARD9 is shown to bind to Rac-GDI protein using the yellow fluorescent protein (YFP)-
based protein complementation assay (PCA/bimolecular fluorescent complementation 
(BiFC) (137). In this method protein-protein interactions will bring two fragments of YFP 
that have been tagged to two separate proteins into close proximity of each other, allowing 
for them to fold into a fluorescent protein (197). 
One of the challenges of immunoprecipitation coupled to mass spectrometry is the 
large numbers of false-positive proteins that are identified in the sample as well as in 
negative controls. Although tandem affinity purification has helped to reduce the level of 
background contaminants it also involves multiple purification steps that may cause the lost 
of transient or weak associations. Although the comparison of the experimental sample to 
the negative control is the first step into filtering the mass spectrometry data, it is still 
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possible that a real high-abundance interacting protein for the given target protein is detected 
at low levels in negative control samples. Therefore, in the field of proteomics designing 
novel methods for quantitative approaches is an active field of investigation. One of these 
new methods to help in quantification of mass spectrometry data is termed Significance 
Analysis of INTeractome (SAINT). This computational approach utilizes label-free 
quantitative data (i.e. Spectral counts) to assign each individual protein-protein complex a 
confidence value (198). To derive the probability of a true protein-protein interaction the 
SAINT algorithm will analyze data from control purifications and generates separate 
distributions for false and true interacting proteins. Although the power of this method of 
statistical analysis of the distributions of spectral counts has not yet been fully tested in 
experiments testing the biological function of specific protein-protein interactions, it may 
prove to enhance current mass spectrometry analysis of novel protein binding partners from 
the unavoidable background.  
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Chapter 6: Summary and Future Perspectives 
 
The results reported in this thesis elucidate a novel cell signaling pathway that our 
innate immune cells utilize, to recognize and combat fungal infections by Candida albicans. 
In our studies, phospholipase γ2, was identified as the main phospholipase activated in 
response to C. albicans. In macrophages, PLCγ2 is crucial for regulating JNK and ERK but 
not p38 pathways in response to C. albicans hyphae. In response to the yeast form of C. 
albicans, PLCγ2-deficient macrophages showed significantly decreased JNK activation 
whereas ERK activation was only partially defective. These results suggest that in response 
to hyphae ERK activation depends solely on PLCγ2 whereas in response to yeast, ERK 
activation is mediated by an additional pathway, possibly the Grb2/ Ras/ Raf1 signaling 
pathway. NF-κB activation in response to C. albicans is not mediated through MyD88. Our 
biochemical analysis revealed that PLCγ2 is required for NF-κB activation in response to 
both the yeast and hyphal form of C. albicans. The activation of the IKK complex 
downstream of the Dectin-2 receptor independently requires both CARD9 and PLCγ2. 
PLCγ2 is required for the production of proinflammatory cytokine and reactive oxygen 
species in innate anti-fungal immune responses. The defective immune response in PLCγ2-
deficient mice in comparison to WT mice was confirmed in vivo by challenging these mice 
with C. albicans. In our in vivo C. albicans infections, PLCγ2-deficient mice showed a 
higher fungal burden and decreased survival rates compared to WT mice. 
  Recent studies using myeloid specific TAK1-deficient mice, reported that peritoneal 
macrophages from TAK1-deficient mice did not show any obvious defects in NF-κB and 
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MAPK activation in response to TLR stimulation compared to WT mice. This finding was 
somewhat unexpected since it had been assumed that TAK1 regulates pattern recognition 
receptor signaling in innate immune cells. In a separate study, utilizing myeloid specific 
TAK1-deficient mice it is reported that these mice have impaired differentiation of bone 
marrow derived macrophages. These macrophages are defective in NF-κB and MAPK 
activation in response to TLR stimulation. In our studies, bone marrow from myeloid 
specific TAK1-deficient mice could not differentiate into macrophages. However, in mice 
that were both TAK1 and TNFR1-deficient, macrophages could be differentiated from their 
bone marrow. In bone marrow derived macrophages TAK1 is critical for NF-κB and MAPK 
activation. TAK1-deficiency decreased the amount of proinflammatory cytokine production, 
which could possibly dampen the adaptive immune system to fight Candida infections and 
increase the susceptibility of these mice to fungal infections. Upon C. albicans stimulation, 
TRAF6 is necessary to mediate NF-κB and MAPK activation. However, the mechanism 
which TAK1 and TRAF6 use to activate the IKK complex in response to C. albicans is 
different. Our results demonstrate that TAK1 regulates the phosphoylation of IKKα/β 
subunits whereas TRAF6 does not. 
Given the complex network of the immune system, the activation of this system is 
strictly regulated. Chronic inflammation caused by stimuli such as fungi has been linked to 
autoimmune diseases such as rheumatoid arthritis and psoriasis (199, 200). A recent study of 
candidemia incidence in unselected hematologic cancer patients at the University of Texas 
M.D. Anderson Cancer Center from 2001 to 2007 reports that the use of older and newer 
prophylaxis antifungal agents did not result in decreased incidence of candidemia (201). 
	  	  	   	  	  	  
	   105	  
Furthermore, despite the use of new antifungal agents attributable and crude mortality rates 
in these patients are still similar to those reported in the older studies (202) and the use of 
combination antifungal treatments did not associate with significant improvements in 
mortality rates (201). We hope that by better understanding the molecular mechanisms that 
regulate innate immune cell signaling we will provide a conceptual framework that will 
enable us to manipulate these responses to provide new therapies for human infection and 
disease. 
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Figure 6. Summary of the proposed model for C-type lectin receptor signaling in 
macrophages. 
 
 
 
 
	  	  	   	  	  	  
	   107	  
Future Perspectives 
 
The studies presented here delineate critical signaling pathways downstream of the 
C-type lectin receptors, which are required for innate host defense against fungal infections 
with C. albicans. These studies raise new questions that should be the topic of future 
investigations. We show that the activation of PLCγ2 is dependent on Syk. However, BTK 
inhibitors could not inhibit the phosphorylation of PLCγ2 or the activation of NF-κB in 
macrophages stimulated by C. albicans hyphae. BTK has a well-established role in BCR 
signaling. Following BCR activation, BTK translocates to the plasma membrane where it is 
phosphorylated by Src family kinases (203). BTK, using the adaptor protein BLNK, can 
phosphorylate PLCγ2, resulting in downstream BCR signaling. The genetic discorder, X-
linked agammaglobulinemia (XLA), which is characterized by loss-of-function mutations in 
the gene that encodes BTK, is characterized by recurrent bacterial and enteroviral infections 
but not fungal infections (204). This suggests that BTK is dispensable in anti-fungal 
immunity. Whether Syk directly phosphorylates PLCγ2 and if BLNK is required for PLCγ2 
activation are questions that need further investigation.  
The negative regulators of C-type lectin receptor signaling have yet to be described. 
In our studies, CYLD-deficient macrophages were not defective in cytokine production or 
NF-κB activation upon C. albicans stimulation. Further studies using A20-knockout 
macrophages will help to clarify the negative regulators of CLR signaling. 
C. albicans can trigger the activation of the cytosolic sensor NLRP3 inflammasome 
(153, 205). The NLRP3 inflammasome controls the activation of caspase-1, which cleaves 
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pro-IL-1β into mature IL-1β in the innate immune cells (206). Studies using Syk inhibitors 
and Syk-deficient dendritic cells show impaired pro-IL-1β production and inflammasome 
activation upon fungal stimulation (153). Furthermore, C. albicans induced inflammasome 
activation depends on Syk mediated ROS production (153). Our studies demonstrate that 
PLCγ2 can mediate hyphae-induced ROS production; Further studies are needed to 
determine if PLCγ2 is mediating inflammasome activation and caspase -1 processing. Aside 
from caspase-1, pro-IL-1β is processed by noncanonical inflammasomes in response to 
TLR4 and TLR3 ligands (207, 208). In DCs stimulated with curdlan, a noncanonical 
caspase-8-MALT1 inflammasome can become activated in a Syk-dependent manner. 
Similar to Syk inhibition, silencing of CARD9, BCL10 or MALT1 abrogated caspase-8 
activity in DCs stimulated with curdlan. Future studies using PLCγ2-deficient macrophages 
to investigate caspase-8 activity will provide insight into the newly discovered noncanonical 
inflammasome activation pathway. 
In addition to the established role of C-type lectin receptor signaling in innate host 
defense, the role of these signaling pathways in the pathogenesis of autoimmune diseases 
remains largely unknown. The majority of studies on commensal microbiota and its link to 
autoimmune diseases have focused on the intestinal bacteria. The interaction between the 
mammalian gut fungal community with innate immune receptor, Dectin-1 was shown to 
influence chemically induced colitis (209). Treatment with the anti-fungal drug Fluconazole 
ameliorated colitis in Dectin-1-deficient mice. A polymorphism in the Dectin-1 gene 
(CLEC7A) is strongly linked with a severe form of ulcerative colitis (209). In the 
gastrointestinal niche, whether other C-type lectin receptors such as Dectin-2 or Mincle 
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influence susceptibility to colitis remains to be investigated. The possibility exisits that 
commensal fungal organisms residing in the intestines not only affect immune responses 
locally, but also can alter immune responses in organs that are not in direct contact with 
intestinal microbiota.  
In the K/BxN T cell receptor transgenic mouse model of inflammatory arthritis, mice 
display attenuated arthritis when housed in germ-free conditions (210). The question 
remains if the K/BxN mouse model would be selectively colonized with specific strains of 
commensal fungi (gnotobiotic), how would this impact arthritis development? Furthermore, 
we could test the impact of C-type lectin receptor signaling in the development of arthritis 
by using the K/BxN serum transfer arthritis model on Dectin-1 or PLCγ2-deficient bone 
marrow chimera mice. It will also be interesting to investigate if Fluconazole treatment in 
the aforementioned experimental setting would ameliorate arthritis symptoms? It is tempting 
to speculate that if the K/BxN serum transfer arthritis model would be conducted under 
germ-free conditions mice will not develop autoimmune arthritis both in PLCγ2-deficient 
and WT mice. However if we reconstitute the mice intestines with one or more commensal 
fungal organisms this will increase arthritis symptoms in WT mice but not in PLCγ2-
deficient mice. 
Type-1 diabetes development in the NOD mouse strain can increase with cleaner 
housing facilities (211). How commensal fungi recognition influences type-1 diabetes 
penetrance has not been investigated. Generating NOD mice crossed with Dectin-1 or 
Dectin-2-deficient mice can be used to determine the role of commensal fungi in the 
pathogenesis of type-1 diabetes. The influence of commensal organisms on autoimmune 
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disease progression cannot be generalized. In the Aire-deficient mouse model of human 
disease, Autoimmune Polyendocrinopathy Syndrome type 1, germ-free facilities did not 
have any significant impact on the severity or progression of this multi-organ autoimmune 
disease (212). The pleiotropic effect of commensal organisms on autoimmune disease 
pathogenesis may in part be explained by the role that certain T helper subsets have in each 
disease. In autoimmune disease mouse models of colitis and rheumatoid arthritis, 
autoreactive Th17 cells have an important role in pathogenicity (210, 213). There is no 
published data demonstrating that Aire- deficiency affects Th17 cell populations, which may 
in part explain why germ-free housing does not have any significant impact on the 
progression of this disease. Dectin-1, Dectin-2 and CARD9 have been implicated in the 
differentiation of Th17 cells (214). Understanding the immune response to mycobiota and 
the affect of these signaling pathways on autoimmune diseases may directly be linked to 
how certain commensal organisms promote differentiation of certain subsets of T helper 
cells, such as Th17 cells in the small-intestinal lamina propria. Future investigations on the 
host innate immune response to commensal fungi may identify better therapeutic strategies 
for fighting invasive fungal infections and provide an opportunity to investigate the 
underlying mechanisms of autoimmune diseases that are influenced by inflammation.  
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